aspirin has been researched along with Arterial Occlusive Diseases in 260 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The Fraxiparin in Stroke Study for the treatment of ischemic stroke (FISS-tris) study showed no superiority of low-molecular-weight heparin (LMWH) over aspirin for the primary end point (Barthel Index) in acute ischemic stroke due to large artery occlusive disease." | 9.16 | Low-molecular-weight heparin versus aspirin for acute ischemic stroke with large artery occlusive disease: subgroup analyses from the Fraxiparin in Stroke Study for the treatment of ischemic stroke (FISS-tris) study. ( Chen, C; Chen, XY; Han, JH; Leung, TW; Mok, V; Soo, Y; Wang, QS; Wong, KS, 2012) |
| " We conducted a pilot study to evaluate the use of the platelet GP IIb/IIIa receptor antagonist abciximab versus aspirin in conjunction with thrombolysis in patients with acute peripheral occlusive arterial disease associated with arterial thrombosis." | 9.09 | Short- and long-term results of abciximab versus aspirin in conjunction with thrombolysis for patients with peripheral occlusive arterial disease and arterial thrombosis. ( Forkmann, L; Hellner, G; Kirch, W; Koch, R; Müller, A; Schweizer, J, 2000) |
| "Individual patient data of patients who received aspirin or placebo after cerebral ischemia were obtained from 9 clinical trials." | 8.82 | Risk of intracerebral hemorrhage in patients with arterial versus cardiac origin of cerebral ischemia on aspirin or placebo: analysis of individual patient data from 9 trials. ( Algra, A; Ariesen, MJ; Koudstaal, PJ; Rothwell, PM; van Walraven, C, 2004) |
| "To determine whether arterial cardiovascular events, use of statins and low-dose aspirin were associated with the risk of venous thromboembolism." | 7.75 | Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study. ( Baron, JA; Christensen, S; Horvath-Puho, E; Johnsen, SP; Prandoni, P; Søgaard, KK; Sørensen, HT; Thomsen, RW, 2009) |
| "Further to characterize the processes involved in the FeCl3-induced thrombosis model, we determined the effect of aspirin, heparin, hirudin, trans-4-(aminomethyl) cyclohexane carboxylic acid (AMCHA), thrombocytopenia, and flow modifications on time to occlusion (TTO) and thrombus weight (TW) in the rat carotid artery." | 7.70 | Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis. ( Kambayashi, J; Lockyer, S, 1999) |
| " We report on the antithrombotic effect of xemilofiban (SC-54684A), an oral GP IIb/IIIa antagonist, administered alone or with aspirin (ASA) in an acute thrombosis model." | 7.70 | Protective effect of oral xemilofiban in arterial thrombosis in dogs: increased activity in combination with aspirin. ( Feigen, LP; Frederick, LG; King, LW; Nicholson, NS; Salyers, AK; Suleymanov, OD; Szalony, JA; Taite, BB, 1998) |
| "After 12 months, restenosis had occurred in 43." | 6.76 | Batroxobin plus aspirin reduces restenosis after angioplasty for arterial occlusive disease in diabetic patients with lower-limb ischemia. ( Cheng, YS; Li, MH; Liu, F; Tan, HQ; Wang, J; Wang, JB; Zhao, JG; Zhu, YQ, 2011) |
| "A review is given on the clinical studies performed with aspirin in patients with chronic vascular occlusions of the limbs and on studies in cerebral ischemia using aspirin and sulfinpyrazone." | 6.14 | Use of platelet inhibitor drugs in peripheral and cerebral vascular disorders. ( Breddin, K, 1977) |
| "Thalidomide has been associated with venous thrombotic events, as reported in the post-marketing surveillance reports by Celgene Corporation; as well as case reports in the literature." | 5.33 | Arterial thrombosis in four patients treated with thalidomide. ( Brown, K; Chanan-Khan, A; Hahn, T; McCarthy, PL; Paplham, P; Roy, H; Scarpace, SL; van Besien, K, 2005) |
| "Aspirin was administered for vascular event prevention." | 5.32 | Aspirin withdrawal and acute lower limb ischemia. ( Albaladejo, P; Castier, Y; Francis, F; Geeraerts, T; Lesèche, G; Marty, J, 2004) |
| "Profound thrombocytopenia has reportedly been an issue with abciximab, but not with tirofiban." | 5.32 | Repetitive profound thrombocytopenia after treatment with tirofiban: a case report. ( Erkoc, R; Eryonucu, B; Tuncer, M, 2004) |
| "A high dose (200 mg/kg) did not inhibit thrombus formation whereas a low dose (20 mg/kg) reduced the incidence of occlusion and the mean thrombus weight." | 5.26 | Effects of 6-[p-(4-phenylacetylpiperazin-l-yl)-phenyl]-4,5-dihydro-3(2H)-pyridazinone (CCl 17810) and aspirin on experimental arterial thrombosis in rats. ( Kumar, A; Lecker, D, 1980) |
| "Accordingly, 50 mg clopidogrel plus aspirin, and 75 mg clopidogrel plus aspirin were all superior to aspirin alone as stroke prevention in patients with cerebral infarction or transient ischemic attack combined with intracranial and extracranial arteriostenosis." | 5.24 | The effectiveness and safety of dual antiplatelet therapy in ischemic cerebrovascular disease with intracranial and extracranial arteriostenosis in Chinese patients: A randomized and controlled trail. ( Dong, AQ; Liu, H; Liu, JQ; Su, N; Wu, HJ; Zuo, FT, 2017) |
| "The Fraxiparin in Stroke Study for the treatment of ischemic stroke (FISS-tris) study showed no superiority of low-molecular-weight heparin (LMWH) over aspirin for the primary end point (Barthel Index) in acute ischemic stroke due to large artery occlusive disease." | 5.16 | Low-molecular-weight heparin versus aspirin for acute ischemic stroke with large artery occlusive disease: subgroup analyses from the Fraxiparin in Stroke Study for the treatment of ischemic stroke (FISS-tris) study. ( Chen, C; Chen, XY; Han, JH; Leung, TW; Mok, V; Soo, Y; Wang, QS; Wong, KS, 2012) |
| "Patients were randomly assigned to receive either subcutaneous LMWH or oral aspirin within 48 hours after stroke onset for 10 days, then all received aspirin once daily for 6 months." | 5.16 | Low-molecular-weight heparin and early neurologic deterioration in acute stroke caused by large artery occlusive disease. ( Chen, C; Chen, XY; Han, JH; Leung, TW; Mok, V; Soo, Y; Wang, Q; Wong, KS, 2012) |
| "After successful PTA, 275 patients with symptomatic peripheral arterial disease (claudication or critical limb ischemia) and femoropopliteal obstructions were randomized to receive either 2500 IU of dalteparin subcutaneously for 3 months plus 100 mg of aspirin daily (n = 137), or 100 mg aspirin daily alone (n = 138)." | 5.12 | Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: a randomized controlled trial. ( Amann-Vesti, BR; Banyai, M; Koppensteiner, R; Meier, T; Pfammatter, T; Rousson, V; Spring, S; van der Loo, B, 2006) |
| "A total of 335 patients (206 men; mean age 72+/-9 years) with intermittent claudication were randomized according to a 2x2 factorial design to 1 of the 4 groups: probucol, placebo, EVBT, and EVBT+probucol." | 5.11 | Effects of probucol versus aspirin and versus brachytherapy on restenosis after femoropopliteal angioplasty: the PAB randomized multicenter trial. ( Alerci, M; Amann-Vesti, B; Aschwanden, M; Baumgartner, I; Bernier, J; Canevascini, R; Cozzi, L; Do, DD; Gallino, A; Greiner, R; Jacob, AL; Jäger, K; Kann, R; Kellner, F; Mahler, F; Schneider, E; Segatto, JM; Studer, G; Triller, J; Tutta, P, 2004) |
| " We conducted a pilot study to evaluate the use of the platelet GP IIb/IIIa receptor antagonist abciximab versus aspirin in conjunction with thrombolysis in patients with acute peripheral occlusive arterial disease associated with arterial thrombosis." | 5.09 | Short- and long-term results of abciximab versus aspirin in conjunction with thrombolysis for patients with peripheral occlusive arterial disease and arterial thrombosis. ( Forkmann, L; Hellner, G; Kirch, W; Koch, R; Müller, A; Schweizer, J, 2000) |
| " The existence of a common pathophysiologic background is also suggested by the evidence that aspirin, low-molecular weight heparin (LMWH) and warfarin are recommended for the prevention and treatment of both venous and arterial thrombosis." | 4.88 | Identifying high-risk individuals for cardiovascular disease: similarities between venous and arterial thrombosis in perspective. A 2011 update. ( Ageno, W; Di Minno, G; Di Minno, MN; Prandoni, P; Tufano, A, 2012) |
| "To assess the clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole (MRD) alone or with aspirin (ASA) compared with ASA (and each other where appropriate) in the prevention of occlusive vascular events in patients with a history of MI, ischaemic stroke/TIA or established peripheral arterial disease." | 4.87 | Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis. ( Bagust, A; Blundell, M; Boland, A; Dickson, R; Dundar, Y; Fisher, M; Greenhalgh, J; Martin Saborido, C; Oyee, J; Proudlove, C, 2011) |
| " The relationship between low-dose aspirin and bleeding was explored by incidence rates and rates per 100 person-years." | 4.84 | Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab. ( Bergsland, E; Gerber, HP; Holden, SN; Holmgren, E; Hurwitz, H; Kabbinavar, F; Miller, K; Ngai, J; Scappaticci, FA; Skillings, JR; Wang, J, 2007) |
| "Individual patient data of patients who received aspirin or placebo after cerebral ischemia were obtained from 9 clinical trials." | 4.82 | Risk of intracerebral hemorrhage in patients with arterial versus cardiac origin of cerebral ischemia on aspirin or placebo: analysis of individual patient data from 9 trials. ( Algra, A; Ariesen, MJ; Koudstaal, PJ; Rothwell, PM; van Walraven, C, 2004) |
| " Among the key recommendations in this chapter are the following: For patients with chronic limb ischemia, we recommend lifelong aspirin therapy in comparison to no antiplatelet therapy in patients with clinically manifest coronary or cerebrovascular disease (Grade 1A) and in those without clinically manifest coronary or cerebrovascular disease (Grade 1C+)." | 4.82 | Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. ( Clagett, GP; Jackson, MR; Lip, GY; Sobel, M; Tangelder, M; Verhaeghe, R, 2004) |
| " It was concluded that the ASA dosage of 1500 mg daily was too high, and produced severe side-effects, probably leading to insufficient patient compliance to therapy." | 3.79 | Oral anticoagulation in peripheral vascular surgery: how intense, for how long, or at all? ( Hölzenbein, TJ; Kretschmer, G, 1999) |
| "Platelet deposition and thrombus formation caused by angioplasty appear to be important in the development of 2 complications: acute thrombotic occlusion and restenosis." | 3.76 | Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty. ( Harker, LA, 1987) |
| "To determine whether arterial cardiovascular events, use of statins and low-dose aspirin were associated with the risk of venous thromboembolism." | 3.75 | Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study. ( Baron, JA; Christensen, S; Horvath-Puho, E; Johnsen, SP; Prandoni, P; Søgaard, KK; Sørensen, HT; Thomsen, RW, 2009) |
| "In the recently published Warfarin Aspirin Recurrent Stroke Study (WARSS), a low-intensity anticoagulation regimen was used because of safety concerns." | 3.72 | Oral anticoagulation in patients after cerebral ischemia of arterial origin and risk of intracranial hemorrhage. ( , 2003) |
| " We report on the antithrombotic effect of xemilofiban (SC-54684A), an oral GP IIb/IIIa antagonist, administered alone or with aspirin (ASA) in an acute thrombosis model." | 3.70 | Protective effect of oral xemilofiban in arterial thrombosis in dogs: increased activity in combination with aspirin. ( Feigen, LP; Frederick, LG; King, LW; Nicholson, NS; Salyers, AK; Suleymanov, OD; Szalony, JA; Taite, BB, 1998) |
| "Ischemic event rates were estimated for 12,931 aspirin users drawn from the Saskatchewan Health population between 1990 and 1995 who had an index diagnosis of myocardial infarction, ischemic stroke, or peripheral arterial disease." | 3.70 | Generalizing the results of clinical trials to actual practice: the example of clopidogrel therapy for the prevention of vascular events. CAPRA (CAPRIE Actual Practice Rates Analysis) Study Group. Clopidogrel versus Aspirin in Patients at Risk of Ischaemi ( Caro, JJ; Migliaccio-Walle, K, 1999) |
| "Further to characterize the processes involved in the FeCl3-induced thrombosis model, we determined the effect of aspirin, heparin, hirudin, trans-4-(aminomethyl) cyclohexane carboxylic acid (AMCHA), thrombocytopenia, and flow modifications on time to occlusion (TTO) and thrombus weight (TW) in the rat carotid artery." | 3.70 | Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis. ( Kambayashi, J; Lockyer, S, 1999) |
| "We describe 13 patients who developed erosive gastritis with overt gastrointestinal bleeding while receiving 75-250 mg nonbuffered aspirin per day for the secondary prevention of cardiac or cerebrovascular events." | 3.68 | Overt gastrointestinal bleeding in the course of chronic low-dose aspirin administration for secondary prevention of arterial occlusive disease. ( Bassan, H; Levy, N; Naschitz, JE; Odeh, M; Rosner, I; Stermer, E; Yeshurun, D, 1990) |
| "Data from the medical treatment group of the Aspirin in TIA study were reviewed, and prospective analysis of patients with asymptomatic bruits was performed to see whether carotid stenosis (0 to 49% or 50 to 99%) or ulceration produced an increased risk of ipsilateral TIA or infarct." | 3.67 | The significance of carotid stenosis or ulceration. ( Bigelow, RH; Fields, WS; Grotta, JC; Hankins, L; Hu, H, 1984) |
| " Pretreatment with carbenicillin, which markedly inhibited platelet aggregation or estradiol cypionate, which induced severe thrombocytopenia, significantly reduced the incidence of sudden death to 9% and zero, respectively." | 3.66 | Effect of inhibition of platelet function with carbenicillin or aspirin on experimental canine sudden death. ( Franciosa, J; Heckel, R; Johnson, GJ; Leis, LA, 1981) |
| "After 12 months, restenosis had occurred in 43." | 2.76 | Batroxobin plus aspirin reduces restenosis after angioplasty for arterial occlusive disease in diabetic patients with lower-limb ischemia. ( Cheng, YS; Li, MH; Liu, F; Tan, HQ; Wang, J; Wang, JB; Zhao, JG; Zhu, YQ, 2011) |
| "The primary end point was restenosis and reocclusion, which was documented by magnetic resonance angiography or duplex scanning at 12-month follow-up." | 2.75 | Batroxobin for prevention of restenosis in diabetic patients after infrapopliteal arterial angioplasty: a small randomized pilot trial. ( Cheng, YS; Li, MH; Liu, F; Tan, HQ; Wang, J; Wang, JB; Zhang, PL; Zhao, JG; Zhu, YQ, 2010) |
| "Dipyridamole was administered in 550 PTCA procedures (455 interventions in men, mean (SD) age 59." | 2.69 | Intracoronary dipyridamole reduces the incidence of abrupt vessel closure following PTCA: a prospective randomised trial. ( Heidland, UE; Heintzen, MP; Kelm, M; Klimek, WJ; Leschke, M; Michel, CJ; Schwartzkopff, B; Strauer, BE; Vester, EG, 2000) |
| "Restenosis was assessed by repeat angiography at 3 months and clinical symptoms up to 12 months." | 2.68 | The effects of platelet inhibitors on platelet uptake and restenosis after femoral angioplasty. ( Fligelstone, LJ; Horrocks, EH; Horrocks, M; Lane, IF; Murphy, P; Ruttley, MS; Watson, HR, 1997) |
| "Taprostene was administered to 19 patients as a continuous intravenous infusion from 2 hours before until 8 (n = 6) or 24 (n = 6) hours after angioplasty; 7 control patients were given a combination of 330 mg aspirin and 75 mg dipyridamole." | 2.68 | [The effect of Taprostene on platelet activation and clinical course after percutaneous transluminal angioplasty]. ( Heinz, M; Söhngen, M; Theiss, W; van de Flierdt, E, 1996) |
| "Behcet's disease was first defined by Hulusi Behcetin 1937 as a multisystemic disorder with characteristic pathologic findings including recurrent orogenitalulcers, vascular disorders, and ocular and cutaneous lesions." | 2.44 | Major arterial involvement and review of Behcet's disease. ( Alpagut, U; Dayioglu, E; Ugurlucan, M, 2007) |
| "Ticlopidine appears to be a reasonable alternative for patients who are hypersensitive to aspirin." | 2.40 | Management of peripheral arterial disease. ( Hilleman, DE, 1998) |
| " Balloon angioplasty with, or without stent deployment appears to be a safe procedure with excellent primary success rate." | 1.37 | [Percutaneous, endovascular treatment of innominate artery lesions is a safe and effective procedure]. ( Bérczi, V; Hüttl, K; Nemes, B; Paukovits, TM, 2011) |
| "Arterial thrombosis was induced by insertion of a silk thread (thrombogenic substrate) into an extracorporeal shunt." | 1.36 | Antithrombotic activity of F 16618, a new PAR1 antagonist evaluated in extracorporeal arterio-venous shunt in the rat. ( Calmettes, Y; Le Grand, B; Leparq-Panissié, A; Létienne, R; Nadal-Wollbold, F; Perez, M, 2010) |
| "Vertebrobasilar insufficiency caused by head rotation is an uncommon event." | 1.35 | Rotational vertebrobasilar insufficiency due to dynamic compression of the dominant vertebral artery by the thyroid cartilage and occlusion of the contralateral vertebral artery at C1-2 level. ( Cross, DT; Dabus, G; Derdeyn, CP; Gerstle, RJ; Moran, CJ; Parsons, M; Thompson, R, 2008) |
| "Thalidomide has been associated with venous thrombotic events, as reported in the post-marketing surveillance reports by Celgene Corporation; as well as case reports in the literature." | 1.33 | Arterial thrombosis in four patients treated with thalidomide. ( Brown, K; Chanan-Khan, A; Hahn, T; McCarthy, PL; Paplham, P; Roy, H; Scarpace, SL; van Besien, K, 2005) |
| "Profound thrombocytopenia has reportedly been an issue with abciximab, but not with tirofiban." | 1.32 | Repetitive profound thrombocytopenia after treatment with tirofiban: a case report. ( Erkoc, R; Eryonucu, B; Tuncer, M, 2004) |
| "Most patients with PAD die of either heart attacks or strokes and they die of the former conditions far earlier than controls." | 1.32 | [Antiplatelet therapy in patients with peripheral arterial disease (PAD)]. ( Diehm, C; Huber, R; Lawall, H, 2004) |
| "A novel model to induce occlusive thrombus formation was developed in mice in vivo." | 1.32 | A novel model of occlusive thrombus formation in mice. ( Cheng, XW; Iguchi, A; Kanda, S; Koike, T; Kuzuya, M; Maeda, K; Nakamura, K; Sasaki, T; Sato, K; Tamaya-Mori, N, 2004) |
| "No or only a mild restenosis developed in 27 patients." | 1.32 | Clinical and angiographic outcome after interventional treatment of the iliac arteries with a new carbofilm coated stent: preliminary results. ( Butz, B; Feuerbach, S; Lenhart, M; Link, J; Paetzel, C; Pfister, K; Schleicher, T; Stern, U, 2004) |
| "Aspirin was administered for vascular event prevention." | 1.32 | Aspirin withdrawal and acute lower limb ischemia. ( Albaladejo, P; Castier, Y; Francis, F; Geeraerts, T; Lesèche, G; Marty, J, 2004) |
| "Arterial thrombosis is initiated following lesion of the vessel wall, either through rupture of an atherosclerotic plaque containing lipids, adhesive proteins and tissue factor or after angioplasty exposing the thrombogenic subendothelial matrix." | 1.32 | [Platelets and arterial thrombosis]. ( Cazenave, JP; Gachet, C; Lanza, F; Wiesel, ML, 2003) |
| "If intermittent claudication is present, angiography of the pelvis and legs then follows." | 1.31 | [Peripheral arterial occlusive disease. Symptoms, basic diagnosis and staged therapy]. ( Grothe, A; Kettmann, R; Welter, HF, 2002) |
| "Indications for surgery included vertebrobasilar insufficiency (22." | 1.30 | Carotid-subclavian bypass for subclavian artery revascularization: long-term follow-up and effect of antiplatelet therapy. ( Dresler, C; Haverich, A; Wahlers, T; Wittwer, T, 1998) |
| " BC2 extended aPTT to a maximum of 60 to 80 seconds at 100 to 1000 nmol/L in vitro (rat and human plasma, respectively) and ex vivo (rat) after dosing of rats up to 6 mg/kg in vivo." | 1.30 | Antithrombotic efficacy of a novel murine antihuman factor IX antibody in rats. ( Baker, A; Blackburn, MN; Bugelski, P; Church, WR; Feuerstein, GZ; Koster, P; Nichols, AJ; Patel, A; Toomey, JR; Valocik, R, 1999) |
| " On the basis of earlier findings that aspirin is able to sensitize platelets to the action of PGI2 and produce beneficial changes in platelet sensitivity, we decided to treat this girl with a daily dosage of 20 mg aspirin orally." | 1.28 | Successful therapy of the prostaglandin defect "Wien-Hietzing" (lack of platelet high-affinity binding sites for prostaglandin I2). ( Gludovacz, D; Kaliman, J; Sinzinger, H; Steurer, G, 1990) |
| " Platelet accumulation at the PTA site occurred with both doses of aspirin, with no differences between the two dosage groups." | 1.28 | Platelet deposition at angioplasty sites and its relation to restenosis in human iliac and femoropopliteal arteries. ( Ahmadi, R; Dudczak, R; Ehringer, H; Jung, M; Koppensteiner, R; Leitha, T; Minar, E; Stümpflen, A, 1989) |
| "Fibromuscular dysplasia is an arteriopathy of unknown etiology that affects the intermediate-size branches of the aorta." | 1.28 | Fibromuscular dysplasia of the carotid arteries complicating pregnancy. ( Beyth, Y; Ezra, Y; Kidron, D, 1989) |
| " In 15 patients the exercise study was done twice; the second time was concurrent with administration of acetylsalicylic acid (ASA) in a dosage of 1." | 1.27 | Lack of elevation of beta-thromboglobulin and platelet factor 4 in plasma during exercise in patients with chronic peripheral arterial occlusive disease. ( Ehringer, H; Minar, E; Schöfl, R, 1987) |
| "Therapy that will reduce acute platelet-thrombus deposition appears to be an important factor for reduction of restenosis." | 1.27 | Restenosis after arterial angioplasty: a hemorrheologic response to injury. ( Badimon, L; Chesebro, JH; Fuster, V; Lam, JY, 1987) |
| "Pretreatment with indomethacin (n = 6) or sodium salicylate (n = 4) almost completely blocked this rise in Qbr." | 1.27 | Regulation of increase in anastomotic blood flow following pulmonary arterial occlusion. ( Butler, J; Jindal, SK; Kirk, W; Lakshminarayanan, S, 1985) |
| "A high dose (200 mg/kg) did not inhibit thrombus formation whereas a low dose (20 mg/kg) reduced the incidence of occlusion and the mean thrombus weight." | 1.26 | Effects of 6-[p-(4-phenylacetylpiperazin-l-yl)-phenyl]-4,5-dihydro-3(2H)-pyridazinone (CCl 17810) and aspirin on experimental arterial thrombosis in rats. ( Kumar, A; Lecker, D, 1980) |
| "One died of subdural hematoma of non-operated side seven months after contralateral bypass procedure." | 1.26 | [Reconstructive operation of Moyamoya disease and its problems (author's transl)]. ( Abe, H; Gotoh, S; Kashiwaba, T; Miyasaka, K; Nakagawa, Y; Ohtsuka, K; Shimoyama, M; Suzuki, Y; Takei, H; Tsuru, M, 1981) |
| "Kawasaki syndrome is a newly described, acute symptom complex of children that has a predictable clinical course." | 1.26 | Kawasaki syndrome: a new infectious disease? ( Melish, ME, 1981) |
| "The aspirin-induced increase in collateral flow was confined to epicardium (12 +/- 4% of normal zone flow at 5 minutes to 23 +/- 4% at 4 hours after occlusion)." | 1.26 | Aspirin-induced increase in collateral flow after acute coronary occlusion in dogs. ( Aamodt, R; Capurro, NL; Epstein, SE; Goldstein, RE; Marr, KC, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 102 (39.23) | 18.7374 |
| 1990's | 52 (20.00) | 18.2507 |
| 2000's | 70 (26.92) | 29.6817 |
| 2010's | 31 (11.92) | 24.3611 |
| 2020's | 5 (1.92) | 2.80 |
| Authors | Studies |
|---|---|
| Kokkinidis, DG | 1 |
| Schizas, D | 1 |
| Pargaonkar, S | 1 |
| Karamanis, D | 1 |
| Mylonas, KS | 1 |
| Hasemaki, N | 1 |
| Palaiodimos, L | 1 |
| Varrias, D | 1 |
| Tzavellas, G | 1 |
| Siasos, G | 1 |
| Klonaris, C | 1 |
| Kharawala, A | 1 |
| Chlorogiannis, DD | 1 |
| Georgopoulos, S | 1 |
| Bakoyiannis, C | 1 |
| Chan, MV | 1 |
| Chen, MH | 1 |
| Barwari, T | 1 |
| Huffman, JE | 1 |
| Armstrong, PC | 1 |
| Hwang, SJ | 1 |
| Santer, P | 1 |
| Wierer, B | 1 |
| Mayr, M | 1 |
| Kiechl, S | 1 |
| Johnson, AD | 1 |
| Willeit, J | 1 |
| Warner, TD | 1 |
| Sadek, G | 1 |
| Santillan, A | 1 |
| Gandy, C | 1 |
| Safi, N | 1 |
| Segal, AZ | 1 |
| Gebauer, K | 1 |
| Wintersohl, K | 1 |
| Kraska, R | 1 |
| Kortendick, K | 1 |
| Fahrland, U | 1 |
| Freisinger, E | 1 |
| Meyborg, M | 1 |
| Stella, J | 1 |
| Engelbertz, C | 1 |
| Reinecke, H | 1 |
| Malyar, N | 1 |
| Chuchvara, N | 1 |
| Alamgir, M | 1 |
| John, AM | 1 |
| Rao, B | 1 |
| Li, X | 1 |
| Zhao, K | 1 |
| Ma, N | 1 |
| Sun, S | 1 |
| Miao, Z | 1 |
| Zhao, Z | 1 |
| Parsons, MR | 1 |
| Stoner, MC | 1 |
| Doyle, A | 1 |
| Mix, D | 1 |
| Cameron, SJ | 1 |
| Li, W | 1 |
| Chen, Z | 1 |
| Dai, Z | 1 |
| Liu, R | 1 |
| Yin, Q | 1 |
| Wang, H | 1 |
| Hao, Y | 1 |
| Han, Y | 1 |
| Qiu, Z | 1 |
| Xiong, Y | 1 |
| Sun, W | 1 |
| Zi, W | 1 |
| Xu, G | 1 |
| Liu, X | 2 |
| Liu, Y | 1 |
| Sun, Y | 1 |
| He, X | 1 |
| Kong, Q | 1 |
| Zhang, Y | 1 |
| Wu, J | 2 |
| Jin, X | 1 |
| Lussana, F | 1 |
| Squizzato, A | 1 |
| Permunian, ET | 1 |
| Cattaneo, M | 1 |
| Ken, J | 1 |
| Khangura, D | 1 |
| Stickles, SP | 1 |
| Huebert, I | 1 |
| Heinicke, N | 1 |
| Kook, D | 1 |
| Boost, KA | 1 |
| Miller, CV | 1 |
| Mayer, WJ | 1 |
| Haritoglou, C | 1 |
| Kampik, A | 1 |
| Gandorfer, A | 1 |
| Hintschich, C | 1 |
| Wolf, A | 1 |
| Beato, J | 1 |
| Fígueira, L | 1 |
| Penas, S | 1 |
| Santos-Silva, R | 1 |
| Falcão, M | 1 |
| Carneiro, Â | 1 |
| Reis, FF | 1 |
| Dake, MD | 1 |
| Ansel, GM | 1 |
| Jaff, MR | 1 |
| Ohki, T | 1 |
| Saxon, RR | 1 |
| Smouse, HB | 1 |
| Machan, LS | 1 |
| Snyder, SA | 1 |
| O'Leary, EE | 1 |
| Ragheb, AO | 1 |
| Zeller, T | 1 |
| Hummel, T | 1 |
| Meves, SH | 1 |
| Rüdiger, K | 1 |
| Mügge, A | 1 |
| Mumme, A | 1 |
| Burkert, B | 1 |
| Mühlberger, D | 1 |
| Neubauer, H | 1 |
| Zuo, FT | 1 |
| Liu, H | 1 |
| Wu, HJ | 1 |
| Su, N | 1 |
| Liu, JQ | 1 |
| Dong, AQ | 1 |
| Sobel, M | 2 |
| Verhaeghe, R | 3 |
| Takeuchi, S | 1 |
| Takasato, Y | 1 |
| Masaoka, H | 1 |
| Hayakawa, T | 1 |
| Otani, N | 1 |
| Yoshino, Y | 1 |
| Yatsushige, H | 1 |
| Sørensen, HT | 1 |
| Horvath-Puho, E | 1 |
| Søgaard, KK | 1 |
| Christensen, S | 1 |
| Johnsen, SP | 1 |
| Thomsen, RW | 1 |
| Prandoni, P | 2 |
| Baron, JA | 1 |
| Linnemann, B | 3 |
| Prochnow, S | 1 |
| Mani, H | 4 |
| Schwonberg, J | 2 |
| Lindhoff-Last, E | 5 |
| De Schryver, EL | 1 |
| Algra, A | 5 |
| Tacke, J | 1 |
| Rechner, AR | 1 |
| Létienne, R | 1 |
| Leparq-Panissié, A | 1 |
| Calmettes, Y | 1 |
| Nadal-Wollbold, F | 1 |
| Perez, M | 1 |
| Le Grand, B | 1 |
| Field-Fote, EC | 1 |
| Liu, L | 1 |
| Zeng, F | 1 |
| Zeng, X | 1 |
| Xue, Q | 1 |
| Nie, S | 1 |
| Kang, C | 1 |
| Kang, Q | 1 |
| Wang, X | 2 |
| Li, T | 1 |
| Chen, J | 1 |
| Li, Q | 1 |
| Xu, R | 1 |
| Yang, X | 1 |
| Kang, H | 1 |
| Jiang, F | 1 |
| Li, Z | 1 |
| Zhang, L | 1 |
| Long, Y | 1 |
| Mehmeti, N | 1 |
| Budak, K | 1 |
| Meier, T | 2 |
| Wang, J | 3 |
| Zhu, YQ | 2 |
| Liu, F | 2 |
| Li, MH | 2 |
| Zhao, JG | 2 |
| Tan, HQ | 2 |
| Wang, JB | 2 |
| Cheng, YS | 2 |
| Zhang, PL | 1 |
| Hughes, GR | 1 |
| Di Minno, MN | 1 |
| Tufano, A | 1 |
| Ageno, W | 1 |
| Di Minno, G | 1 |
| Schneider, JR | 2 |
| Verta, MJ | 1 |
| Alonzo, MJ | 1 |
| Hahn, D | 1 |
| Patel, NH | 1 |
| Kim, S | 1 |
| Greenhalgh, J | 1 |
| Bagust, A | 1 |
| Boland, A | 1 |
| Martin Saborido, C | 1 |
| Oyee, J | 1 |
| Blundell, M | 1 |
| Dundar, Y | 1 |
| Dickson, R | 1 |
| Proudlove, C | 1 |
| Fisher, M | 1 |
| Duschek, N | 1 |
| Vafaie, M | 1 |
| Skrinjar, E | 1 |
| Hirsch, K | 1 |
| Waldhör, T | 1 |
| Hübl, W | 1 |
| Bergmayr, W | 1 |
| Knoebl, P | 1 |
| Assadian, A | 1 |
| Paukovits, TM | 1 |
| Nemes, B | 1 |
| Hüttl, K | 1 |
| Bérczi, V | 1 |
| Bang, OY | 1 |
| Kim, JS | 1 |
| Wang, QS | 1 |
| Chen, C | 3 |
| Chen, XY | 2 |
| Han, JH | 2 |
| Soo, Y | 2 |
| Leung, TW | 2 |
| Mok, V | 2 |
| Wong, KS | 3 |
| Wiesemann, S | 1 |
| Passlick, B | 1 |
| Wang, Q | 1 |
| Meyer, S | 1 |
| Soga, Y | 1 |
| Tomoi, Y | 1 |
| Sato, K | 2 |
| Iida, O | 1 |
| Yokoi, H | 1 |
| Welter, HF | 1 |
| Kettmann, R | 1 |
| Grothe, A | 1 |
| Avegliano, G | 1 |
| Evangelista, A | 1 |
| Elorz, C | 1 |
| González-Alujas, T | 1 |
| García del Castillo, H | 1 |
| Soler-Soler, J | 1 |
| Turpie, AG | 2 |
| Hiller, E | 1 |
| McDermott, MM | 1 |
| Guralnik, JM | 1 |
| Greenland, P | 1 |
| Pearce, WH | 1 |
| Criqui, MH | 1 |
| Liu, K | 1 |
| Taylor, L | 1 |
| Chan, C | 1 |
| Sharma, L | 1 |
| Ridker, PM | 1 |
| Green, D | 1 |
| Quann, M | 1 |
| Wohlgemuth, WA | 1 |
| Bohndorf, K | 1 |
| Dörffler-Melly, J | 1 |
| Schmidli, J | 1 |
| Mahler, F | 3 |
| Strecker, EP | 1 |
| Boos, IB | 1 |
| Göttmann, D | 1 |
| Vetter, S | 1 |
| Yilmaz, S | 1 |
| Sindel, T | 1 |
| Yegin, A | 1 |
| Lüleci, E | 1 |
| Ziegler, S | 2 |
| Alt, E | 2 |
| Brunner, M | 2 |
| Speiser, W | 2 |
| Minar, E | 8 |
| Cazenave, JP | 1 |
| Gachet, C | 1 |
| Lanza, F | 1 |
| Wiesel, ML | 1 |
| Wilhite, DB | 1 |
| Comerota, AJ | 1 |
| Schmieder, FA | 1 |
| Throm, RC | 1 |
| Gaughan, JP | 1 |
| Rao, AK | 1 |
| Nakajima, M | 1 |
| Kimura, K | 1 |
| Minematsu, K | 1 |
| Saito, K | 1 |
| Takada, T | 1 |
| Tanaka, M | 1 |
| Ariesen, MJ | 1 |
| Koudstaal, PJ | 1 |
| Rothwell, PM | 1 |
| van Walraven, C | 1 |
| Panneton, JM | 1 |
| Hollier, LH | 1 |
| Hofer, JM | 1 |
| Albaladejo, P | 1 |
| Geeraerts, T | 1 |
| Francis, F | 1 |
| Castier, Y | 1 |
| Lesèche, G | 1 |
| Marty, J | 1 |
| Barlas, S | 1 |
| Tansel, T | 1 |
| Sasaki, T | 1 |
| Kuzuya, M | 1 |
| Cheng, XW | 1 |
| Nakamura, K | 1 |
| Tamaya-Mori, N | 1 |
| Maeda, K | 1 |
| Kanda, S | 1 |
| Koike, T | 1 |
| Iguchi, A | 1 |
| Poulsen, TS | 2 |
| Mickley, H | 1 |
| Kovacs, MJ | 1 |
| Kearon, C | 1 |
| Rodger, M | 1 |
| Anderson, DR | 1 |
| Bates, SM | 1 |
| Desjardins, L | 1 |
| Douketis, J | 1 |
| Kahn, SR | 1 |
| Solymoss, S | 1 |
| Wells, PS | 1 |
| Aronow, WS | 1 |
| Clagett, GP | 5 |
| Jackson, MR | 2 |
| Lip, GY | 1 |
| Tangelder, M | 1 |
| Conforto, AB | 1 |
| Puglia, P | 1 |
| Yamamoto, FI | 1 |
| Scaff, M | 1 |
| Diehm, C | 2 |
| Lawall, H | 1 |
| Huber, R | 1 |
| Butz, B | 1 |
| Paetzel, C | 1 |
| Stern, U | 1 |
| Schleicher, T | 1 |
| Pfister, K | 1 |
| Link, J | 1 |
| Feuerbach, S | 1 |
| Lenhart, M | 1 |
| Gallino, A | 1 |
| Do, DD | 1 |
| Alerci, M | 1 |
| Baumgartner, I | 1 |
| Cozzi, L | 1 |
| Segatto, JM | 1 |
| Bernier, J | 1 |
| Tutta, P | 1 |
| Kellner, F | 1 |
| Triller, J | 1 |
| Schneider, E | 2 |
| Amann-Vesti, B | 1 |
| Studer, G | 1 |
| Jäger, K | 1 |
| Aschwanden, M | 1 |
| Canevascini, R | 1 |
| Jacob, AL | 1 |
| Kann, R | 1 |
| Greiner, R | 1 |
| Scarpace, SL | 1 |
| Hahn, T | 1 |
| Roy, H | 1 |
| Brown, K | 1 |
| Paplham, P | 1 |
| Chanan-Khan, A | 1 |
| van Besien, K | 1 |
| McCarthy, PL | 1 |
| Eryonucu, B | 1 |
| Tuncer, M | 1 |
| Erkoc, R | 1 |
| Durand-Zaleski, I | 1 |
| Bertrand, M | 2 |
| Weintraub, W | 1 |
| Jönsson, B | 1 |
| Klinkhardt, U | 1 |
| Harder, S | 1 |
| Hoefer, IE | 1 |
| Grundmann, S | 1 |
| Schirmer, S | 1 |
| van Royen, N | 1 |
| Meder, B | 1 |
| Bode, C | 1 |
| Piek, JJ | 1 |
| Buschmann, IR | 1 |
| White, WB | 1 |
| Parke, AL | 1 |
| Billett, HH | 1 |
| Tulsyan, N | 1 |
| Ouriel, K | 1 |
| Kashyap, VS | 1 |
| Heiss, JM | 1 |
| Wong, S | 1 |
| Morel-Kopp, MC | 1 |
| Chen, Q | 1 |
| Appleberg, M | 1 |
| Ward, CM | 1 |
| Lewis, DR | 1 |
| Lechat, P | 1 |
| Priollet, P | 1 |
| Luxembourg, B | 2 |
| Kirchmayr, K | 1 |
| Collins, P | 1 |
| Ford, I | 1 |
| Greaves, M | 2 |
| Macaulay, E | 1 |
| Brittenden, J | 1 |
| Singer, E | 1 |
| Imfeld, S | 1 |
| Hoffmann, U | 1 |
| Buschmann, I | 1 |
| Labs, KH | 1 |
| Jaeger, KA | 1 |
| Koppensteiner, R | 6 |
| Spring, S | 1 |
| Amann-Vesti, BR | 1 |
| Pfammatter, T | 1 |
| Rousson, V | 1 |
| Banyai, M | 1 |
| van der Loo, B | 1 |
| Alpagut, U | 1 |
| Ugurlucan, M | 1 |
| Dayioglu, E | 1 |
| Ng, PW | 1 |
| Tsoi, TH | 1 |
| Li, HL | 1 |
| Fong, WC | 1 |
| Yeung, J | 1 |
| Wong, CK | 1 |
| Yip, KK | 1 |
| Gao, H | 1 |
| Wong, HB | 1 |
| Toennes, SW | 1 |
| Strubel, G | 1 |
| Klaeffling, C | 1 |
| Daemgen-von Brevern, G | 1 |
| Geisen, C | 1 |
| Mortensen, J | 1 |
| Refsgaard, J | 1 |
| Kristensen, SD | 1 |
| Scappaticci, FA | 1 |
| Skillings, JR | 1 |
| Holden, SN | 1 |
| Gerber, HP | 1 |
| Miller, K | 1 |
| Kabbinavar, F | 1 |
| Bergsland, E | 1 |
| Ngai, J | 1 |
| Holmgren, E | 1 |
| Hurwitz, H | 1 |
| Dabus, G | 1 |
| Gerstle, RJ | 1 |
| Parsons, M | 1 |
| Cross, DT | 1 |
| Moran, CJ | 1 |
| Thompson, R | 1 |
| Derdeyn, CP | 1 |
| Landolfi, R | 1 |
| Di Gennaro, L | 1 |
| Hans, GA | 1 |
| Senard, M | 1 |
| Ledoux, D | 1 |
| Grayet, B | 1 |
| Scholtes, F | 1 |
| Creemers, E | 1 |
| Lamy, ML | 1 |
| Il'in, VN | 1 |
| Stepanov, NV | 1 |
| Ikhaev, ZA | 1 |
| Sharonin, GV | 1 |
| Bogdanets, LI | 1 |
| Heidrich, H | 2 |
| Bergqvist, D | 1 |
| Goldman, MD | 1 |
| Simpson, D | 1 |
| Hawker, RJ | 1 |
| Norcott, HC | 1 |
| McCollum, CN | 1 |
| Vittoria, A | 1 |
| Guerrini, M | 1 |
| Pieragalli, D | 1 |
| Del Bigo, C | 1 |
| Martelli, G | 1 |
| Franchi, M | 1 |
| Messa, G | 1 |
| Blardi, P | 1 |
| Galigani, C | 1 |
| Di Perri, T | 2 |
| Antignani, PL | 1 |
| Bollinger, A | 4 |
| Biland, L | 1 |
| Brunner, U | 2 |
| Kappert, A | 1 |
| Krähenbühl, B | 1 |
| Monti, M | 1 |
| Nachbur, B | 1 |
| Widmer, LK | 1 |
| Born, GV | 1 |
| Görög, P | 1 |
| Begent, NA | 1 |
| Kistler, JP | 1 |
| Ropper, AH | 1 |
| Heros, RC | 1 |
| Youkey, JR | 1 |
| Brigham, RA | 1 |
| Orecchia, PM | 1 |
| Salander, JM | 1 |
| Collins, GJ | 1 |
| Rich, NM | 1 |
| Viinikka, L | 1 |
| Lewy, RI | 1 |
| Cain, TD | 1 |
| Wood, JS | 1 |
| Beard, OW | 1 |
| Heinrich, F | 1 |
| Rushton, FW | 1 |
| Kukora, JS | 1 |
| Grotta, JC | 1 |
| Bigelow, RH | 1 |
| Hu, H | 1 |
| Hankins, L | 1 |
| Fields, WS | 1 |
| Green, RM | 1 |
| Roedersheimer, LR | 1 |
| DeWeese, JA | 1 |
| Soyka, D | 1 |
| Newman, PE | 1 |
| Cristol, R | 1 |
| Baker, RI | 1 |
| Pitney, WR | 1 |
| Zabel-Langhennig, R | 1 |
| Ruttmann, B | 1 |
| Schiele, I | 1 |
| Schäfer, W | 1 |
| Aisch, W | 1 |
| Melish, ME | 1 |
| Nakagawa, Y | 1 |
| Shimoyama, M | 1 |
| Kashiwaba, T | 1 |
| Suzuki, Y | 1 |
| Gotoh, S | 2 |
| Miyasaka, K | 1 |
| Takei, H | 1 |
| Ohtsuka, K | 1 |
| Abe, H | 1 |
| Tsuru, M | 1 |
| Johnson, GJ | 1 |
| Heckel, R | 1 |
| Leis, LA | 1 |
| Franciosa, J | 1 |
| Fukushige, J | 1 |
| Nihill, MR | 1 |
| McNamara, DG | 1 |
| Levin, SM | 1 |
| Sondheimer, FK | 1 |
| Levin, JM | 1 |
| Lecker, D | 1 |
| Kumar, A | 1 |
| Russo, M | 1 |
| Hufnagel, H | 1 |
| Fitzgerald, GA | 1 |
| Meagher, EA | 1 |
| Stalnikowicz-Darvasi, R | 1 |
| Ahmadi, A | 1 |
| Maca, T | 1 |
| Stümpflen, A | 4 |
| Ugurluoglu, A | 1 |
| Ehringer, H | 6 |
| van den Berkmortel, FW | 1 |
| Wollersheim, H | 1 |
| Heijstraten, FM | 1 |
| Thien, T | 1 |
| Skaria, AM | 1 |
| Hauser, C | 1 |
| Allegra, C | 1 |
| Pollari, G | 1 |
| Carioti, B | 1 |
| Sardina, M | 1 |
| Shirakura, S | 1 |
| Higo, K | 1 |
| Takeda, M | 1 |
| Karasawa, A | 1 |
| David, M | 1 |
| Patrono, C | 1 |
| Weichert, W | 1 |
| Meents, H | 1 |
| Abt, K | 1 |
| Lieb, H | 1 |
| Hach, W | 1 |
| Krzywanek, HJ | 1 |
| Breddin, HK | 1 |
| Rosendaal, FR | 1 |
| van Gijn, J | 2 |
| Ranke, C | 4 |
| Creutzig, A | 4 |
| Alexander, K | 4 |
| Luska, G | 2 |
| Wagner, HH | 2 |
| Galanski, M | 2 |
| Bode-Böger, S | 1 |
| Frölich, J | 1 |
| Avenarius, HJ | 2 |
| Hecker, H | 2 |
| Zeitler, E | 4 |
| Beyer-Enke, S | 1 |
| Rompel, O | 1 |
| Peters, FP | 1 |
| Doevendans, PA | 1 |
| Erdkamp, FL | 1 |
| Van Der Ent, FW | 1 |
| De Heer, F | 1 |
| Castillo, V | 1 |
| Bogousslavsky, J | 1 |
| Vuadens, P | 1 |
| Sivaguru, A | 1 |
| Venables, GS | 1 |
| Beard, JD | 1 |
| Gaines, PA | 1 |
| Diethrich, EB | 1 |
| Ndiaye, M | 1 |
| Reid, DB | 1 |
| Heinz, M | 1 |
| Theiss, W | 1 |
| van de Flierdt, E | 1 |
| Söhngen, M | 1 |
| Stiegler, H | 1 |
| Dapling, RB | 1 |
| Snowden, JA | 1 |
| West, J | 1 |
| Talbot, JF | 1 |
| Nelson, ME | 1 |
| Goodfield, M | 1 |
| Horrocks, M | 1 |
| Horrocks, EH | 1 |
| Murphy, P | 1 |
| Lane, IF | 1 |
| Ruttley, MS | 1 |
| Fligelstone, LJ | 1 |
| Watson, HR | 1 |
| Mueller, MR | 1 |
| Salat, A | 1 |
| Stangl, P | 1 |
| Murabito, M | 1 |
| Pulaki, S | 1 |
| Boehm, D | 1 |
| Ergun, E | 1 |
| Mittlboeck, M | 1 |
| Schreiner, W | 1 |
| Losert, U | 1 |
| Wolner, E | 1 |
| Wittwer, T | 1 |
| Wahlers, T | 1 |
| Dresler, C | 1 |
| Haverich, A | 1 |
| Frederick, LG | 1 |
| Suleymanov, OD | 1 |
| Szalony, JA | 1 |
| Taite, BB | 1 |
| Salyers, AK | 1 |
| King, LW | 1 |
| Feigen, LP | 1 |
| Nicholson, NS | 1 |
| Bertrand, ME | 1 |
| Legrand, V | 1 |
| Boland, J | 1 |
| Fleck, E | 1 |
| Bonnier, J | 1 |
| Emmanuelson, H | 1 |
| Vrolix, M | 1 |
| Missault, L | 1 |
| Chierchia, S | 1 |
| Casaccia, M | 1 |
| Niccoli, L | 1 |
| Oto, A | 1 |
| White, C | 1 |
| Webb-Peploe, M | 1 |
| Van Belle, E | 1 |
| McFadden, EP | 1 |
| Hilleman, DE | 1 |
| Baumgartner, RW | 1 |
| Mattle, HP | 1 |
| Schroth, G | 1 |
| Michelini, S | 1 |
| Micci, A | 1 |
| Failla, A | 1 |
| Moneta, G | 1 |
| Ottaviani, A | 1 |
| Lockyer, S | 1 |
| Kambayashi, J | 1 |
| Kretschmer, G | 3 |
| Hölzenbein, TJ | 1 |
| Feuerstein, GZ | 1 |
| Patel, A | 1 |
| Toomey, JR | 1 |
| Bugelski, P | 1 |
| Nichols, AJ | 1 |
| Church, WR | 1 |
| Valocik, R | 1 |
| Koster, P | 1 |
| Baker, A | 1 |
| Blackburn, MN | 1 |
| Hafner, J | 1 |
| Caro, JJ | 1 |
| Migliaccio-Walle, K | 1 |
| Heintzen, MP | 1 |
| Heidland, UE | 1 |
| Klimek, WJ | 1 |
| Leschke, M | 1 |
| Kelm, M | 1 |
| Schwartzkopff, B | 1 |
| Vester, EG | 1 |
| Michel, CJ | 1 |
| Strauer, BE | 1 |
| Kawano, KI | 1 |
| Fujishima, K | 1 |
| Ikeda, Y | 1 |
| Kondo, K | 1 |
| Umemura, K | 1 |
| Poliantsev, AA | 1 |
| Spasov, AA | 1 |
| Mozgovoĭ, PV | 1 |
| Karpenko, AV | 1 |
| Shcherbakov, VN | 1 |
| Kuznetsov, VI | 1 |
| Khomutnikova, AI | 1 |
| Kirichenko, OM | 1 |
| Schweizer, J | 2 |
| Kirch, W | 1 |
| Koch, R | 1 |
| Müller, A | 1 |
| Hellner, G | 1 |
| Forkmann, L | 1 |
| Abendschein, DR | 1 |
| Baum, PK | 1 |
| Verhallen, P | 1 |
| Eisenberg, PR | 1 |
| Sullivan, ME | 1 |
| Light, DR | 1 |
| Gusak, VK | 1 |
| Shtutin, AA | 1 |
| Rodin, IuV | 1 |
| Il'iushchenko, SV | 1 |
| Iurchuk, AIu | 1 |
| Haldemann, R | 1 |
| Lüscher, TF | 1 |
| Szucs, TD | 1 |
| Klijn, CJ | 1 |
| Kappelle, LJ | 1 |
| Bartorelli, AL | 1 |
| Trabattoni, D | 1 |
| Montorsi, P | 1 |
| Fabbiocchi, F | 1 |
| Galli, S | 1 |
| Ravagnani, P | 1 |
| Grancini, L | 1 |
| Cozzi, S | 1 |
| Loaldi, A | 1 |
| Roller, RE | 1 |
| Dorr, A | 1 |
| Ulrich, S | 1 |
| Pilger, E | 3 |
| Pöhlmann, G | 1 |
| Bär, H | 1 |
| Siegmund, R | 1 |
| Eidner, G | 1 |
| Figulla, HR | 1 |
| Verstraete, M | 2 |
| Vigdahl, RL | 1 |
| Ferber, RH | 1 |
| Parrish, SL | 1 |
| Breddin, K | 2 |
| Zicot, M | 1 |
| Weissbach, G | 1 |
| Bedford, RF | 1 |
| Ashford, TP | 1 |
| De Mey, C | 1 |
| Wellens, D | 1 |
| Vanhoutte, PM | 1 |
| Grobe, T | 1 |
| Ostendorf, P | 1 |
| Capurro, NL | 1 |
| Marr, KC | 1 |
| Aamodt, R | 1 |
| Goldstein, RE | 1 |
| Epstein, SE | 1 |
| Roncucci, R | 1 |
| Deperon, R | 1 |
| Destailleur, J | 1 |
| Doumont, J | 1 |
| Lambelin, G | 1 |
| Lansen, J | 1 |
| Moriau, M | 1 |
| Van Stalle, F | 1 |
| Preuss, EG | 1 |
| Meng, K | 1 |
| Seuter, F | 1 |
| Loew, D | 5 |
| Regli, F | 1 |
| Michaud, PA | 1 |
| Evangelisti, GB | 1 |
| Faggioli, F | 1 |
| Garagnani, A | 1 |
| Lama, G | 1 |
| Hess, H | 2 |
| Müller-Fassbender, H | 1 |
| Ingrisch, H | 1 |
| Mietaschk, A | 2 |
| Duncan, GW | 1 |
| Pessin, MS | 1 |
| Mohr, JP | 1 |
| Adams, RD | 1 |
| Ehresmann, U | 1 |
| Alemany, J | 1 |
| Boehme, K | 1 |
| Artik, N | 1 |
| Wu, KK | 2 |
| Hoak, JC | 1 |
| Ruggiero, A | 1 |
| Teramo, A | 1 |
| Mauro, C | 1 |
| Genton, E | 2 |
| Gent, M | 1 |
| Hirsh, J | 1 |
| Harker, LA | 3 |
| Browder, A | 1 |
| Browder, J | 1 |
| Fregnan, GB | 1 |
| Chieli, T | 1 |
| Pfeiffer, W | 1 |
| Frölich, JC | 1 |
| Norden, C | 1 |
| Reimann, H | 1 |
| Grunow, G | 1 |
| Misselwitz, F | 1 |
| Lammer, J | 1 |
| Bertuch, H | 1 |
| Stark, G | 1 |
| Decrinis, M | 1 |
| Pfeiffer, KP | 1 |
| Krejs, GJ | 1 |
| Tønnesen, KH | 1 |
| Holstein, P | 1 |
| Andersen, E | 1 |
| Mase, K | 1 |
| Yasunaga, K | 1 |
| Altmann, E | 1 |
| Spranger, C | 1 |
| Hoffmann, A | 1 |
| Schmidt, PK | 1 |
| Buring, JE | 1 |
| Hennekens, CH | 1 |
| McCollum, C | 1 |
| Kenchington, G | 1 |
| Alexander, C | 1 |
| Franks, PJ | 1 |
| Greenhalgh, RM | 1 |
| Yasuda, K | 1 |
| Matsui, Y | 1 |
| Goda, T | 1 |
| Sakuma, M | 1 |
| Go, K | 1 |
| Rossmann, E | 1 |
| Gruber, E | 1 |
| Pratschner, T | 1 |
| Schemper, M | 1 |
| Piza, F | 1 |
| Zekert, F | 1 |
| Polterauer, P | 2 |
| Függer, R | 1 |
| Prager, M | 1 |
| Sautner, T | 1 |
| Steurer, G | 1 |
| Kaliman, J | 3 |
| Gludovacz, D | 1 |
| Sinzinger, H | 3 |
| Frauchiger, B | 1 |
| Naschitz, JE | 1 |
| Yeshurun, D | 1 |
| Odeh, M | 1 |
| Bassan, H | 1 |
| Rosner, I | 1 |
| Stermer, E | 1 |
| Levy, N | 1 |
| Ahmadi, R | 2 |
| Dudczak, R | 1 |
| Leitha, T | 1 |
| Jung, M | 3 |
| Salzman, EW | 1 |
| Hobson, RW | 2 |
| Towne, J | 1 |
| Lewin, J | 1 |
| Swedenborg, J | 1 |
| Egberg, N | 1 |
| Vesterqvist, O | 1 |
| Green, K | 1 |
| Ezra, Y | 1 |
| Kidron, D | 1 |
| Beyth, Y | 1 |
| Deichsel, G | 1 |
| Schöfl, R | 1 |
| Chesebro, JH | 1 |
| Lam, JY | 1 |
| Badimon, L | 1 |
| Fuster, V | 1 |
| Brewer, ML | 1 |
| Kinnison, ML | 1 |
| Perler, BA | 1 |
| White, RI | 1 |
| Eckstein, HH | 1 |
| Müller-Bühl, U | 1 |
| Zimmermann, R | 1 |
| Gilligan, BS | 1 |
| Hainaut, P | 1 |
| Lavenne, E | 1 |
| Magy, JM | 1 |
| Lebacq, EG | 1 |
| Hacke, W | 1 |
| Zeumer, H | 1 |
| Ferbert, A | 1 |
| Brückmann, H | 1 |
| del Zoppo, GJ | 1 |
| Silberbauer, K | 1 |
| Fitscha, P | 2 |
| Rauscha, F | 1 |
| Freeman, JW | 1 |
| Tuhrim, S | 1 |
| Reggia, JA | 1 |
| Runge, E | 1 |
| Thiele, P | 1 |
| Jindal, SK | 1 |
| Lakshminarayanan, S | 1 |
| Kirk, W | 1 |
| Butler, J | 1 |
| Long, JB | 1 |
| Lynch, TG | 1 |
| Karanfilian, RG | 1 |
| Bunt, TJ | 1 |
| Haynes, JL | 1 |
| Rubin, JR | 1 |
| Goldstone, J | 1 |
| Mocchi, N | 1 |
| Sbalzarini, G | 1 |
| Cantaluppi, P | 1 |
| Gewirtz, H | 1 |
| Sasken, H | 1 |
| Steiner, M | 1 |
| Most, AS | 1 |
| Szirmai, E | 1 |
| Sachs, V | 1 |
| Hynes, KM | 1 |
| Gau, GT | 1 |
| Rutherford, BD | 1 |
| Kazmier, FJ | 1 |
| Frye, RL | 1 |
| Reichold, J | 1 |
| Schoop, W | 1 |
| Bousser, MG | 1 |
| Lecrubier, C | 1 |
| Scharrer, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Stent Implantation Versus Balloon Dilation for Acute Anterior Circulation Tandem Occlusion: A Multicenter, Prospective, Randomized, Open-label, Blinded End-point Trial[NCT05902000] | 222 participants (Anticipated) | Interventional | 2023-06-14 | Recruiting | |||
| A Multicenter, Randomized, Controlled, Superiority Clinical Trial to Evaluate the Safety and Efficacy of Drug-eluting Peripheral Arterial Stent System（G-stream） in the Treatment of the Above-the-knee Femoropopliteal Artery Stenosis or Occlusion[NCT05780359] | 280 participants (Anticipated) | Interventional | 2022-05-27 | Recruiting | |||
| Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery[NCT00120406] | 474 participants (Actual) | Interventional | 2005-03-31 | Completed | |||
| Efficacy and Safety of Tirofiban in Patients With Acute Branch Atheromatous Disease (BAD)- Related Stroke (BRANT)[NCT06037889] | Phase 3 | 516 participants (Anticipated) | Interventional | 2023-11-09 | Recruiting | ||
| [NCT00035776] | 0 participants | Observational | 2001-01-31 | Completed | |||
| Ovine Graft (Omniflow II) Versus PTFE in Below Knee Arterial Reconstruction: A Prospective Randomized Multi Centre Study[NCT00845585] | 0 participants (Actual) | Interventional | 2009-01-31 | Withdrawn (stopped due to found not enough centers for recruitment) | |||
| A Double Blind Randomized Control Trial of Post-Operative Low Molecular Weight Heparin Bridging Therapy Versus Placebo Bridging Therapy for Patients Who Are at High Risk for Arterial Thromboembolism (PERIOP 2)[NCT00432796] | Phase 3 | 1,473 participants (Actual) | Interventional | 2006-12-31 | Active, not recruiting | ||
| Randomized, Monocentric and Multidisciplinary Study of the Effects of an Intensive Rehabilitation by Interval Training With Active Recovery in Peripheral Arterial Disease With Claudication[NCT01734603] | Phase 3 | 40 participants (Actual) | Interventional | 2011-10-31 | Completed | ||
| A Multicenter, Open-Label, Phase III, Randomized, Active-Controlled Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of rhuMAb VEGF (Bevacizumab), in Combination With Capecitabine Chemotherapy, in Subjects With Previously Treated Metastatic Bre[NCT00109239] | Phase 3 | 0 participants | Interventional | 2000-11-30 | Completed | ||
| A Phase III, Multicenter, Randomized, Active-Controlled Clinical Trial to Evaluate the Efficacy and Safety of rhuMAb VEGF (Bevacizumab) in Combination With Standard Chemotherapy in Subjects With Metastatic Colorectal Cancer[NCT00109070] | Phase 3 | 0 participants | Interventional | 2000-09-30 | Completed | ||
| A Phase II, Multicenter, Double-Blind, Randomized, Active-Controlled Clinical Trial to Evaluate the Efficacy and Safety of rhuMAb VEGF (Bevacizumab), a Recombinant Humanized Monoclonal Antibody to Vascular Endothelial Growth Factor, in Combination With 5-[NCT00109226] | Phase 2 | 0 participants | Interventional | 2000-08-31 | Completed | ||
| WilL LOWer Dose Aspirin be More Effective Following ACS? (WILLOW-ACS)[NCT02741817] | Phase 4 | 20 participants (Actual) | Interventional | 2016-06-26 | Completed | ||
| The Impact of Aspirin Dose Modification on the Innate Immune Response - Will Lower Dose Aspirin Therapy Reduce the Response to Endotoxin[NCT03869268] | Phase 4 | 72 participants (Actual) | Interventional | 2019-04-24 | Completed | ||
| Characterisation of a Novel Regimen of Very Low-dose Aspirin Combined With Rivaroxaban in Patients With Chronic Coronary Syndromes: WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes?[NCT04990791] | Phase 4 | 48 participants (Anticipated) | Interventional | 2021-08-26 | Recruiting | ||
| Aspirin for the Prevention of Preeclampsia in Women With Stage 1 Hypertension: A Pilot Study[NCT04908982] | Phase 4 | 60 participants (Anticipated) | Interventional | 2021-05-28 | Recruiting | ||
| Evaluation of Neurological Outcome in Patients Undergoing Cerebral Angiography and Revascularization Using Angioplasty and Stent-Supported Angioplasty[NCT00597974] | 108 participants (Actual) | Observational | 2003-09-30 | Completed | |||
| Antiplatelet Resistance Research in Patients With Peripheral Arterial Revascularization[NCT03953547] | 88 participants (Actual) | Observational | 2018-01-01 | Completed | |||
| A Post-Market, Prospective, Multi-Center, Study to Evaluate Safety and Efficacy of the StarClose™ Vascular Closure System in Patients Who Are Ambulated Early Post-Diagnostic Catheterization[NCT00736086] | 165 participants (Actual) | Observational | 2006-03-31 | Completed | |||
| [NCT00000527] | Phase 2 | 0 participants | Interventional | 1986-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"Event-free survival is defined as freedom from the major adverse events of death, target lesion revascularization, target limb ischemia requiring surgical intervention (bypass or amputation of toe, foot or leg), surgical repair of the target vessel (e.g., dissection requiring surgery), and from worsening of the Rutherford classification by 2 classes or to class 5 or 6.~Participant flow is based on initial randomization of Zilver PTX or PTA (Percutaneous balloon angioplasty), and Event-free survival is based on Per-Protocol analysis where only patients who were treated according to their initial randomization are counted." (NCT00120406)
Timeframe: 12 months
| Intervention | Percentage of participants (Number) |
|---|---|
| Zilver PTX | 90.4 |
| PTA (Control) | 83.9 |
Primary patency is defined as a Peak systolic velocity (PSV) ratio < 2.0 or angiographic percent diameter stenosis < 50%. (NCT00120406)
Timeframe: 12 months
| Intervention | Percentage of participants (Number) |
|---|---|
| Zilver PTX | 82.7 |
| PTA (Control) | 32.7 |
55 reviews available for aspirin and Arterial Occlusive Diseases
| Article | Year |
|---|---|
A systematic review on the effect of aspirin in the prevention of post-operative arterial thrombosis in patients undergoing total hip and total knee arthroplasty.
Topics: Anticoagulants; Arterial Occlusive Diseases; Arthroplasty, Replacement, Hip; Arthroplasty, Replaceme | 2014 |
Secondary stroke prevention with antithrombotic drugs.
Topics: Arterial Occlusive Diseases; Aspirin; Brain Ischemia; Cyclooxygenase Inhibitors; Dipyridamole; Drug | 2010 |
[Medicinal therapy for interventional surgery of the peripheral vascular system].
Topics: Administration, Oral; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Drug Therap | 2010 |
Revaluation of clopidogrel: let the data speak for themselves.
Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Cost-Benefit Analysis; Drug Therapy, Combination; | 2010 |
Identifying high-risk individuals for cardiovascular disease: similarities between venous and arterial thrombosis in perspective. A 2011 update.
Topics: Arterial Occlusive Diseases; Aspirin; Cardiovascular Diseases; Comorbidity; Female; Humans; Incidenc | 2012 |
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.
Topics: Arterial Occlusive Diseases; Aspirin; Brain Ischemia; Clopidogrel; Cost-Benefit Analysis; Delayed-Ac | 2011 |
State of the art--a journey through the world of antithrombotic therapy.
Topics: Ambulatory Care; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Coronary Disease; Fibrinolytic A | 2002 |
[Endovascular brachytherapy to prevent restenosis after angioplasty].
Topics: Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Arterial Occlusive Diseases; Aspirin; Brachyth | 2003 |
Risk of intracerebral hemorrhage in patients with arterial versus cardiac origin of cerebral ischemia on aspirin or placebo: analysis of individual patient data from 9 trials.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arterial Occlusive Diseases; Aspirin; Atrial Fibrillation; | 2004 |
Antiplatelet therapy in peripheral arterial disease.
Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Dipyridamole; Humans; Peripheral Vascular Disease | 2004 |
Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Arterial Occlusive Diseases; Aspirin; Cilostazol; Clopidogrel; Contraindications; Evidence-Based Med | 2004 |
The value of clopidogrel versus aspirin in reducing atherothrombotic events: the CAPRIE study.
Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Cost-Benefit Analysis; Humans; Multicenter Studie | 2004 |
The value of clopidogrel in addition to standard therapy in reducing atherothrombotic events.
Topics: Angioplasty, Balloon, Coronary; Arterial Occlusive Diseases; Aspirin; Benchmarking; Clopidogrel; Dru | 2004 |
Antiplatelet agents and arterial thrombosis.
Topics: Age Factors; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Dose-R | 2006 |
Emerging drugs in peripheral arterial disease.
Topics: Administration, Oral; Anticoagulants; Arterial Occlusive Diseases; Arteries; Aspirin; Clopidogrel; D | 2006 |
[Prevention of major ischemic events in lower limb arterial disease: does aspirin play a role?].
Topics: Arterial Occlusive Diseases; Aspirin; Humans; Ischemia; Leg; Platelet Aggregation Inhibitors; Risk F | 2006 |
Major arterial involvement and review of Behcet's disease.
Topics: Adrenal Cortex Hormones; Adult; Aneurysm, False; Anticoagulants; Aortic Aneurysm, Abdominal; Arteria | 2007 |
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Com | 2007 |
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Com | 2007 |
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Com | 2007 |
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Com | 2007 |
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Com | 2007 |
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Com | 2007 |
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Com | 2007 |
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Com | 2007 |
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Com | 2007 |
[Peripheral arterial occlusions. Principles, possibilities and limits of conservative therapy].
Topics: Ancrod; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cardiomyopathies; Dextrans; Digitalis | 1981 |
Pharmacological prevention of thrombotic occlusion in arterial reconstructive surgery.
Topics: Arachidonic Acid; Arachidonic Acids; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Cyclic A | 1983 |
The biologic background to some therapeutic uses of aspirin.
Topics: Animals; Arterial Occlusive Diseases; Aspirin; Carotid Artery Diseases; Coronary Disease; Humans; In | 1983 |
Therapy of ischemic cerebral vascular disease due to atherothrombosis. (2).
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Auscultation; Basilar Artery; Blood Platelets; | 1984 |
An antagonist of prostaglandin synthesis in cardiovascular diseases.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Brain Diseases; Cardiovascular Diseases; Con | 1984 |
Medical Grand Rounds: extracranial carotid artery disease.
Topics: Adolescent; Adult; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Auscultation; Carotid Art | 1980 |
[Specific measures in drug therapy in stroke. Anticoagulants, inhibitors of thrombocyte aggregation, initial barbiturate therapy].
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Barbiturates; Carotid Arteries; Cerebral Infar | 1980 |
The coronary collateral circulation: determinants and functional significance in ischemic heart disease.
Topics: Adolescent; Animals; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Aspirin; Blood Pressure; Col | 1981 |
[Platelet antiaggregants and arteriopathies].
Topics: Arterial Occlusive Diseases; Aspirin; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyr | 1981 |
Antiplatelet drugs.
Topics: Animals; Arterial Occlusive Diseases; Aspirin; Dipyridamole; Humans; Integrins; Platelet Aggregation | 1994 |
Gastrointestinal bleeding during low-dose aspirin administration for prevention of arterial occlusive events. A critical analysis.
Topics: Aged; Arterial Occlusive Diseases; Aspirin; Clinical Trials as Topic; Drug Administration Schedule; | 1995 |
Aspirin as an antiplatelet drug.
Topics: Arterial Occlusive Diseases; Aspirin; Cardiovascular Diseases; Drug Interactions; Humans; Platelet A | 1994 |
Aspirin as an antiplatelet drug.
Topics: Arterial Occlusive Diseases; Aspirin; Cardiovascular Diseases; Drug Interactions; Humans; Platelet A | 1994 |
Aspirin as an antiplatelet drug.
Topics: Arterial Occlusive Diseases; Aspirin; Cardiovascular Diseases; Drug Interactions; Humans; Platelet A | 1994 |
Aspirin as an antiplatelet drug.
Topics: Arterial Occlusive Diseases; Aspirin; Cardiovascular Diseases; Drug Interactions; Humans; Platelet A | 1994 |
Aspirin as an antiplatelet drug.
Topics: Arterial Occlusive Diseases; Aspirin; Cardiovascular Diseases; Drug Interactions; Humans; Platelet A | 1994 |
Aspirin as an antiplatelet drug.
Topics: Arterial Occlusive Diseases; Aspirin; Cardiovascular Diseases; Drug Interactions; Humans; Platelet A | 1994 |
Aspirin as an antiplatelet drug.
Topics: Arterial Occlusive Diseases; Aspirin; Cardiovascular Diseases; Drug Interactions; Humans; Platelet A | 1994 |
Aspirin as an antiplatelet drug.
Topics: Arterial Occlusive Diseases; Aspirin; Cardiovascular Diseases; Drug Interactions; Humans; Platelet A | 1994 |
Aspirin as an antiplatelet drug.
Topics: Arterial Occlusive Diseases; Aspirin; Cardiovascular Diseases; Drug Interactions; Humans; Platelet A | 1994 |
Aspirin as an antiplatelet drug.
Topics: Arterial Occlusive Diseases; Aspirin; Cardiovascular Diseases; Drug Interactions; Humans; Platelet A | 1994 |
Aspirin as an antiplatelet drug.
Topics: Arterial Occlusive Diseases; Aspirin; Cardiovascular Diseases; Drug Interactions; Humans; Platelet A | 1994 |
Aspirin as an antiplatelet drug.
Topics: Arterial Occlusive Diseases; Aspirin; Cardiovascular Diseases; Drug Interactions; Humans; Platelet A | 1994 |
Aspirin as an antiplatelet drug.
Topics: Arterial Occlusive Diseases; Aspirin; Cardiovascular Diseases; Drug Interactions; Humans; Platelet A | 1994 |
Aspirin as an antiplatelet drug.
Topics: Arterial Occlusive Diseases; Aspirin; Cardiovascular Diseases; Drug Interactions; Humans; Platelet A | 1994 |
Aspirin as an antiplatelet drug.
Topics: Arterial Occlusive Diseases; Aspirin; Cardiovascular Diseases; Drug Interactions; Humans; Platelet A | 1994 |
Aspirin as an antiplatelet drug.
Topics: Arterial Occlusive Diseases; Aspirin; Cardiovascular Diseases; Drug Interactions; Humans; Platelet A | 1994 |
[Acetylsalicylic acid in arterial circulatory disorders. Which dosage in which indication?].
Topics: Arterial Occlusive Diseases; Aspirin; Blood Circulation; Cerebrovascular Disorders; Coronary Disease | 1994 |
[Preventive treatment of cerebrovascular accidents of arterial origin].
Topics: Adult; Aged; Anticoagulants; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Clinical Trials | 1996 |
Optimal management of chronic leg ulcers in the elderly.
Topics: Administration, Oral; Aged; Aging; Arterial Occlusive Diseases; Aspirin; Bandages; Combined Modality | 1997 |
Management of peripheral arterial disease.
Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Ticlopid | 1998 |
Antithrombotic therapy in peripheral arterial occlusive disease.
Topics: Angioplasty, Balloon, Coronary; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Endarterectomy, C | 1998 |
Oral anticoagulation in peripheral vascular surgery: how intense, for how long, or at all?
Topics: Administration, Oral; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Drug Administration Sche | 1999 |
Management of arterial leg ulcers and of combined (mixed) venous-arterial leg ulcers.
Topics: Alprostadil; Arterial Occlusive Diseases; Aspirin; Bandages; Electric Stimulation Therapy; Exercise | 1999 |
Outcome in patients with symptomatic occlusion of the internal carotid artery or intracranial arterial lesions: a meta-analysis of the role of baseline characteristics and type of antithrombotic treatment.
Topics: Administration, Oral; Aged; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Carotid Artery, In | 2001 |
Use of platelet inhibitor drugs in peripheral and cerebral vascular disorders.
Topics: Arterial Occlusive Diseases; Aspirin; Blood Platelets; Brain Ischemia; Cell Survival; Clinical Trial | 1977 |
[is there a treatment for peripheral arterial insufficiency?].
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Clofibrate; Dipyridamole; Fibrinolytic Agent | 1979 |
[Thrombosis prevention and treatment in pediatrics].
Topics: Adolescent; Arterial Occlusive Diseases; Aspirin; Bioprosthesis; Child; Child, Preschool; Coumarins; | 1979 |
Physiopathology and pharmacotherapy of occlusive arterial disorders.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Blood Platelets; Blood Viscosity; Cerebrovas | 1979 |
[Transient ischemia attacks in general practice].
Topics: Anticoagulants; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Carotid Arteries; Diagnosis, | 1979 |
Transient cerebral ischemic attacks.
Topics: Anticoagulants; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Blindn | 1976 |
Are agents affecting platelet functions clinically useful?
Topics: Aged; Animals; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Clofibrate; Dextrans; Dipyrida | 1976 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Tria | 1975 |
[Therapy of arterial occlusive disease].
Topics: Arterial Occlusive Diseases; Aspirin; Fish Oils; Humans; Platelet Aggregation Inhibitors; Prostaglan | 1990 |
Antithrombotic therapy in peripheral vascular disease.
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis; Humans; Platelet Aggr | 1989 |
Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty.
Topics: Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Aspirin; Clinical Trials as Topic; Dipyr | 1987 |
[Significance of acetylsalicylic acid in the secondary prevention of peripheral arterial occlusive diseases].
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Endarterectomy; Humans; Postoperative Ca | 1988 |
Antiplatelet drugs in the management of patients with thrombotic disorders.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Blood Platelets | 1986 |
Transient ischaemic attacks: controversies in treatment. A review.
Topics: Arterial Occlusive Diseases; Aspirin; Carotid Artery Diseases; Endarterectomy; Humans; Ischemic Atta | 1988 |
[Acetylsalicylic acid therapy in vascular diseases].
Topics: Arterial Occlusive Diseases; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary | 1988 |
The management of TIAs in 1986.
Topics: Arterial Occlusive Diseases; Aspirin; Carotid Artery Diseases; Cerebrovascular Disorders; Dipyridamo | 1986 |
Asymptomatic carotid disease.
Topics: Arterial Occlusive Diseases; Aspirin; Brain Ischemia; Carotid Artery Diseases; Cerebrovascular Disor | 1985 |
60 trials available for aspirin and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial.
Topics: Adult; Aged; Angioplasty; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Combine | 2016 |
Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial.
Topics: Adult; Aged; Angioplasty; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Combine | 2016 |
Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial.
Topics: Adult; Aged; Angioplasty; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Combine | 2016 |
Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial.
Topics: Adult; Aged; Angioplasty; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Combine | 2016 |
[Prevalence of acetylsalicylic acid (ASA) - low response in vascular surgery].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Arterial Occlusive Diseases; Aspirin; Carotid Stenosi | 2016 |
The effectiveness and safety of dual antiplatelet therapy in ischemic cerebrovascular disease with intracranial and extracranial arteriostenosis in Chinese patients: A randomized and controlled trail.
Topics: Arterial Occlusive Diseases; Aspirin; China; Clopidogrel; Dose-Response Relationship, Drug; Drug The | 2017 |
Variability of non-response to aspirin in patients with peripheral arterial occlusive disease during long-term follow-up.
Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Aspirin; Drug Resistance; Female; Follo | 2009 |
Assessment of clopidogrel non-response by the PFA-100 system using the new test cartridge INNOVANCE PFA P2Y.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Catheterization, Per | 2010 |
Batroxobin for prevention of restenosis in diabetic patients after infrapopliteal arterial angioplasty: a small randomized pilot trial.
Topics: Aged; Amputation, Surgical; Angioplasty; Ankle Brachial Index; Arterial Occlusive Diseases; Aspirin; | 2010 |
Batroxobin plus aspirin reduces restenosis after angioplasty for arterial occlusive disease in diabetic patients with lower-limb ischemia.
Topics: Aged; Analysis of Variance; Angioplasty; Arterial Occlusive Diseases; Aspirin; Batroxobin; China; Co | 2011 |
Comparison of enoxaparin and unfractionated heparin in endovascular interventions for the treatment of peripheral arterial occlusive disease: a randomized controlled trial.
Topics: Aged; Arterial Occlusive Diseases; Aspirin; Drug Therapy, Combination; Endothelium, Vascular; Enoxap | 2011 |
Low-molecular-weight heparin versus aspirin for acute ischemic stroke with large artery occlusive disease: subgroup analyses from the Fraxiparin in Stroke Study for the treatment of ischemic stroke (FISS-tris) study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arterial Occlusive Diseases; As | 2012 |
Low-molecular-weight heparin and early neurologic deterioration in acute stroke caused by large artery occlusive disease.
Topics: Aged; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Chi-Square Distribution; Drug Administra | 2012 |
Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Ankle; Arterial Occlusi | 2003 |
Managing PAD with multiple platelet inhibitors: the effect of combination therapy on bleeding time.
Topics: Aged; Arterial Occlusive Diseases; Aspirin; Bleeding Time; Cilostazol; Clopidogrel; Drug Therapy, Co | 2003 |
Multicenter randomized prospective trial comparing a pre-cuffed polytetrafluoroethylene graft to a vein cuffed polytetrafluoroethylene graft for infragenicular arterial bypass.
Topics: Aged; Aged, 80 and over; Anastomosis, Surgical; Anticoagulants; Arterial Occlusive Diseases; Aspirin | 2004 |
Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Atrial Fibrillation; Blood Loss, Surgical; Coh | 2004 |
Effects of probucol versus aspirin and versus brachytherapy on restenosis after femoropopliteal angioplasty: the PAB randomized multicenter trial.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Angioplasty, Balloon; Arterial Occlusive Diseases; As | 2004 |
Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Cardiovascular Disea | 2006 |
Aspirin in peripheral arterial disease: breakthrough or pitfall?
Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Collateral Circulation; Combined Modality Therapy | 2006 |
Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: a randomized controlled trial.
Topics: Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Dalteparin; Drug Therapy, Combinat | 2006 |
Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Arterial Occlusive Diseases; A | 2007 |
Aspirin and dipyridamole reduce platelet deposition on prosthetic femoro-popliteal grafts in man.
Topics: Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis; Clinical Trials as Topic; Dipyridamol | 1983 |
Asymptomatic cervical bruit and abnormal ocular pneumoplethysmography: a prospective study comparing two approaches to management.
Topics: Aged; Angiography; Arterial Occlusive Diseases; Aspirin; Auscultation; Carotid Arteries; Carotid Art | 1984 |
Medical Grand Rounds: extracranial carotid artery disease.
Topics: Adolescent; Adult; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Auscultation; Carotid Art | 1980 |
Effects of aspirin and dipyridamole on expanded polytetrafluoroethylene graft patency.
Topics: Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis; Clinical Trials as Topic; Dipyridamol | 1982 |
[5-year controlled therapy study on the prevention of diabetic angiopathy with the platelet-function inhibitor acetylsalicylic acid].
Topics: Adult; Arterial Occlusive Diseases; Aspirin; Brain Ischemia; Coronary Disease; Diabetic Angiopathies | 1982 |
Comparison of effects of high-dose and low-dose aspirin on restenosis after femoropopliteal percutaneous transluminal angioplasty.
Topics: Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Combined Modality Therapy; Dose-Re | 1995 |
Thrombin and platelet inhibition with low-dose calcium-heparin in comparison with ASA in patients with peripheral arterial occlusive disease at Leriche-Fontaine IIb class.
Topics: Administration, Oral; Aged; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Exercise Test; Fe | 1994 |
Acetylsalicylic acid--reocclusion--prophylaxis after angioplasty (ARPA-study). A randomized double-blind trial of two different dosages of ASA in patients with peripheral occlusive arterial disease.
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Combined Modality Therapy; Dose-Response | 1994 |
[Dose-dependent side effects of acetylsalicylic acid therapy. Results of a prospective randomized clinical study in patients with peripheral arterial occlusive disease].
Topics: Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Dose-Response Relationship, Drug; | 1993 |
European carotid angioplasty trial.
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Carotid Artery Diseases; Carotid Artery, | 1996 |
[The effect of Taprostene on platelet activation and clinical course after percutaneous transluminal angioplasty].
Topics: Administration, Oral; Adult; Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Cardi | 1996 |
The effects of platelet inhibitors on platelet uptake and restenosis after femoral angioplasty.
Topics: Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Constriction, Pathologic; Female; | 1997 |
Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty.
Topics: Administration, Oral; Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Blood Platel | 1997 |
Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study.
Topics: Administration, Oral; Aged; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Coronary Disease; | 1998 |
Assessment of >/=50% and <50% intracranial stenoses by transcranial color-coded duplex sonography.
Topics: Adult; Aged; Arterial Occlusive Diseases; Aspirin; Carotid Arteries; Carotid Stenosis; Cerebral Angi | 1999 |
[Study on the efficacy of ginkgo biloba extract, magnesium and levo-arginine in the treatment of patients with 2d stage arteriopathies. A preliminary study].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Arterial Occlusive Diseases; Aspirin; Drug | 1998 |
Oral anticoagulation in peripheral vascular surgery: how intense, for how long, or at all?
Topics: Administration, Oral; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Drug Administration Sche | 1999 |
Intracoronary dipyridamole reduces the incidence of abrupt vessel closure following PTCA: a prospective randomised trial.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Arterial Occlusive Diseases; Aspirin; C | 2000 |
Short- and long-term results of abciximab versus aspirin in conjunction with thrombolysis for patients with peripheral occlusive arterial disease and arterial thrombosis.
Topics: Abciximab; Aged; Antibodies, Monoclonal; Arterial Occlusive Diseases; Aspirin; Female; Fibrinolytic | 2000 |
[Application of preparation endotelon in complex treatment of chronic arterial insufficiency of lower extremities].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Arterial Occlusive Diseases; Aspirin; Biflavo | 2000 |
Aspirin alone antiplatelet regimen after intracoronary placement of the Carbostent: the ANTARES study.
Topics: Adult; Aged; Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis Implantation; Carbon; Coa | 2002 |
Effect of aspirin treatment in patients with peripheral arterial disease monitored with the platelet function analyzer PFA-100.
Topics: Adenosine Triphosphate; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Aspirin; Blood | 2002 |
Internation Committee on Thrombosis and Haemostasis Basil, 8.-11. September 1974 Subcommittee on Clinical Investigations: Registry of prospective clinical trials.
Topics: Ancrod; Animals; Arterial Occlusive Diseases; Aspirin; Batroxobin; Clinical Trials as Topic; Fibrino | 1975 |
Use of platelet inhibitor drugs in peripheral and cerebral vascular disorders.
Topics: Arterial Occlusive Diseases; Aspirin; Blood Platelets; Brain Ischemia; Cell Survival; Clinical Trial | 1977 |
Aspirin pretreatment prevents post-cannulation radial-artery thrombosis.
Topics: Aged; Arterial Occlusive Diseases; Arteries; Aspirin; Catheterization; Clinical Trials as Topic; Dou | 1979 |
[Prevention of re-occlusion after recanalisation of occluded arteries by the catheter method (author's transl)].
Topics: Arterial Occlusive Diseases; Aspirin; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; | 1978 |
[The action of various drugs in the prevention of re-occlusion following Dotter's catheter disobliteration].
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Bencyclane; Catheterization; Clinical Trials a | 1976 |
[Use of acetylsalicylic acid in the prevention of re-occlusion following revascularization interventions. Results of a double-blind long term study].
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Double-Blind Method; Female; Follow-Up Studi | 1977 |
[Planning, realization, and biometric evaluation of a long term study with acetylsalicylic acid].
Topics: Aged; Arterial Occlusive Diseases; Aspirin; Biometry; Female; Follow-Up Studies; Humans; Male; Middl | 1977 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Tria | 1975 |
[Comparison of 50 mg and 900 mg/day acetylsalicylic acid for prevention of recurrence after percutaneous transluminal angioplasty of the lower extremities: results of the LARA study].
Topics: Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Combined Modality Therapy; Dose-Re | 1992 |
Nd:YAG laser with sapphire tip combined with balloon angioplasty in peripheral arterial occlusions. Long-term results.
Topics: Aged; Angioplasty, Balloon; Angioplasty, Laser; Arterial Occlusive Diseases; Aspirin; Dipyridamole; | 1991 |
PTFE or HUV for femoro-popliteal bypass: a multi-centre trial.
Topics: Arterial Occlusive Diseases; Aspirin; Bioprosthesis; Blood Vessel Prosthesis; Combined Modality Ther | 1991 |
[Acetylsalicylic acid after iliac-femoro-popliteal interventions?].
Topics: Arterial Occlusive Diseases; Aspirin; Combined Modality Therapy; Femoral Artery; Humans; Iliac Arter | 1991 |
[Synthetic vascular reconstructions in the pelvis: function and survival].
Topics: Aortic Diseases; Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis; Combined Modality Th | 1990 |
Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. A prospective double-blind arteriographically controlled trial.
Topics: Arterial Occlusive Diseases; Aspirin; Blood Platelets; Clinical Trials as Topic; Dipyridamole; Doubl | 1985 |
Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty.
Topics: Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Aspirin; Clinical Trials as Topic; Dipyr | 1987 |
[Acetylsalicylic acid therapy in vascular diseases].
Topics: Arterial Occlusive Diseases; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary | 1988 |
Asymptomatic carotid disease.
Topics: Arterial Occlusive Diseases; Aspirin; Brain Ischemia; Carotid Artery Diseases; Cerebrovascular Disor | 1985 |
Effect of aspirin on brachial artery occlusion following brachial arteriotomy for coronary arteriography.
Topics: Administration, Oral; Angiography; Arterial Occlusive Diseases; Aspirin; Blood Pressure; Brachial Ar | 1973 |
[Effect of acteylsalicylic acid on early results following percutaneous recanalisation of arterial occlusions (Dotter's method)].
Topics: Arterial Occlusive Diseases; Aspirin; Endarterectomy; Evaluation Studies as Topic; Femoral Artery; F | 1973 |
152 other studies available for aspirin and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Differences between Lower Extremity Arterial Occlusion vs. Stenosis and Predictors of Successful Endovascular Interventions.
Topics: Arterial Occlusive Diseases; Aspirin; Chronic Disease; Constriction, Pathologic; Endovascular Proced | 2023 |
Platelet Reactivity in Individuals Over 65 Years Old Is Not Modulated by Age.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Arterial Occlusive Diseases; Aspirin; Blood Platelets; | 2020 |
Cilioretinal artery occlusion in a patient with hereditary spherocytosis post-splenectomy.
Topics: Arterial Occlusive Diseases; Aspirin; Ciliary Arteries; Humans; Male; Middle Aged; Platelet Aggregat | 2020 |
[Medication-based secondary prevention in patients with peripheral arterial occlusive disease : An analysis based on secondary data].
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Humans; Peripheral Arterial Disease; Platelet | 2021 |
Dermal Filler-Induced Vascular Occlusion Successfully Treated With Tadalafil, Hyaluronidase, and Aspirin.
Topics: Adult; Arterial Occlusive Diseases; Aspirin; Cosmetic Techniques; Dermal Fillers; Drug Therapy, Comb | 2021 |
Association of ABCB1 promoter methylation with aspirin exposure, platelet function, and clinical outcomes in Chinese intracranial artery stenosis patients.
Topics: Arterial Occlusive Diseases; Aspirin; ATP Binding Cassette Transporter, Subfamily B; Case-Control St | 2017 |
Lights Out: An Unusual Case of Amaurosis Fugax.
Topics: Amaurosis Fugax; Angiography, Digital Subtraction; Anticholesteremic Agents; Arterial Occlusive Dise | 2018 |
Management of acute tandem occlusions: Stent-retriever thrombectomy with emergency stenting or angioplasty.
Topics: Aged; Angioplasty; Arterial Occlusive Diseases; Aspirin; Brain Ischemia; Carotid Artery Diseases; Cl | 2018 |
Imaging diagnosis and surgical treatment of popliteal artery entrapment syndrome: a single-center experience.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anticoagulants; Arterial Occlusive Diseases; Aspirin; | 2014 |
Point-of-care Ultrasound to Identify Distal Ulnar Artery Thrombosis: Case of Hypothenar Hammer Syndrome.
Topics: Adult; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Emergency Medical Services; Humans; Mal | 2015 |
Dual platelet inhibition in cases of severe retrobulbar hemorrhage following retrobulbar and peribulbar anesthesia.
Topics: Aged; Anesthesia, Local; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cardiac Surgical Proc | 2015 |
Presumed bilateral cilioretinal artery occlusion related to relapsing white dot syndrome.
Topics: Arterial Occlusive Diseases; Aspirin; Ciliary Arteries; Coloring Agents; Drug Therapy, Combination; | 2016 |
Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Topics: Arterial Occlusive Diseases; Aspirin; Evidence-Based Medicine; Fibrinolytic Agents; Heparin; Humans; | 2008 |
[Case of vertebral artery occlusion caused by transverse process fracture of C7].
Topics: Accidents, Traffic; Adult; Arterial Occlusive Diseases; Aspirin; Cervical Vertebrae; Heparin; Humans | 2008 |
Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Aspirin; Case-Control Studies; Female; Humans; | 2009 |
Antithrombotic activity of F 16618, a new PAR1 antagonist evaluated in extracorporeal arterio-venous shunt in the rat.
Topics: Animals; Arterial Occlusive Diseases; Arteriovenous Shunt, Surgical; Aspirin; Bleeding Time; Clopido | 2010 |
Does the dose do it?
Topics: Arterial Occlusive Diseases; Aspirin; Exercise; Guidelines as Topic; Humans; Nervous System Diseases | 2009 |
[Diagnosis of peripheral arterial occlusive disease].
Topics: Algorithms; Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Blood Pressure Determination | 2010 |
Hughes syndrome (the antiphospholipid syndrome): a disease of our time.
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Arterial Occlusive D | 2011 |
Results with Viabahn-assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive disease.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Ankle Brachial Index; Anticoagulants; Arterial Occlus | 2011 |
[Percutaneous, endovascular treatment of innominate artery lesions is a safe and effective procedure].
Topics: Aged; Angioplasty, Balloon; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Brachiocephalic Tr | 2011 |
Low-molecular-weight heparin in atherosclerotic stroke: a surprising resurrection of anticoagulants?
Topics: Antifibrinolytic Agents; Arterial Occlusive Diseases; Aspirin; Brain Ischemia; Female; Humans; Intra | 2012 |
[Perioperative management of antiplatelet therapy in thoracic surgery. A survey of German hospitals].
Topics: Arterial Occlusive Diseases; Aspirin; Attitude of Health Personnel; Brain Ischemia; Clopidogrel; Com | 2012 |
[Platelet inhibition in clinical practice].
Topics: Aged; Angioplasty, Balloon, Coronary; Arterial Occlusive Diseases; Aspirin; Cerebral Infarction; Clo | 2012 |
Clinical outcome after endovascular treatment for isolated common femoral and popliteal artery disease.
Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Aspirin; Dose-Response Relationship, Dr | 2013 |
[Peripheral arterial occlusive disease. Symptoms, basic diagnosis and staged therapy].
Topics: Amputation, Surgical; Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Exercise; Humans; | 2002 |
Acute peripheral arterial ischemia and suspected aortic dissection: usefulness of transesophageal echocardiography in differential diagnosis with aortic thrombosis.
Topics: Acute Disease; Adult; Aged; Amputation, Surgical; Anticoagulants; Aortic Diseases; Arterial Occlusiv | 2002 |
[Long-term anticoagulation after bypass operation].
Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Humans; Long-Term Care; Platelet Aggregation Inhi | 2002 |
[Anticoagulation and antiaggregation in patients with peripheral arterial occlusive diseases].
Topics: Administration, Oral; Angioplasty, Balloon; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Bl | 2003 |
Oral anticoagulation in patients after cerebral ischemia of arterial origin and risk of intracranial hemorrhage.
Topics: Anticoagulants; Arterial Occlusive Diseases; Asia, Southeastern; Aspirin; Brain Ischemia; Dipyridamo | 2003 |
Clopidogrel plus long-term aspirin after femoro-popliteal stenting. The CLAFS project: 1- and 2-year results.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Angiography; Angioplasty, Balloon; Anticoagula | 2004 |
Subintimal angioplasty of long superficial femoral artery occlusions.
Topics: Angioplasty; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Female; Femoral Artery; Fibrinolytic | 2003 |
Influence of systemic inflammation on efficiency of antiplatelet therapy in PAOD patients.
Topics: Arterial Occlusive Diseases; Aspirin; C-Reactive Protein; Female; Humans; Inflammation; Male; Periph | 2004 |
[Platelets and arterial thrombosis].
Topics: Adenosine Diphosphate; Angioplasty, Balloon; Anti-Bacterial Agents; Arterial Occlusive Diseases; Art | 2003 |
A case of frequently recurring amaurosis fugax with atherothrombotic ophthalmic artery occlusion.
Topics: Amaurosis Fugax; Angiography, Digital Subtraction; Arterial Occlusive Diseases; Arteriosclerosis; As | 2004 |
Aspirin withdrawal and acute lower limb ischemia.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Aspirin; Chronic Disease; Female; Humans; Isch | 2004 |
Antiphospholipid syndrome in a child: an insight into the pathology, identification, and means of cure.
Topics: Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; Arterial Occlusive Diseases; | 2004 |
A novel model of occlusive thrombus formation in mice.
Topics: Animals; Arterial Occlusive Diseases; Aspirin; Carotid Artery Diseases; Carotid Artery, Common; Dise | 2004 |
Is the antiplatelet effect of aspirin affected by systemic inflammation?
Topics: Arterial Occlusive Diseases; Aspirin; Blood Platelets; Drug Resistance; Humans; Inflammation; Platel | 2004 |
Progressive cervicocranial arteriopathy with dilatations and stenoses: case report.
Topics: Adult; Arterial Occlusive Diseases; Aspirin; Basilar Artery; Carotid Artery Diseases; Carotid Artery | 2004 |
[Antiplatelet therapy in patients with peripheral arterial disease (PAD)].
Topics: Arterial Occlusive Diseases; Aspirin; Cause of Death; Cerebral Infarction; Clopidogrel; Coronary Art | 2004 |
[Attack on many vascular fronts. Atherothrombosis trouble seldom comes alone].
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Clinical Trials as Topic; Clopidogrel; | 2004 |
[Patients with arterial occlusive disease die of myocardial infarct or stroke. The dangerous sisters: arterial occlusive disease and coronary heart disease].
Topics: Aged; Arterial Occlusive Diseases; Aspirin; Cause of Death; Clinical Trials as Topic; Clopidogrel; C | 2004 |
Clinical and angiographic outcome after interventional treatment of the iliac arteries with a new carbofilm coated stent: preliminary results.
Topics: Administration, Oral; Aged; Aged, 80 and over; Angiography; Anticoagulants; Arterial Occlusive Disea | 2004 |
Arterial thrombosis in four patients treated with thalidomide.
Topics: Aged; Arterial Occlusive Diseases; Aspirin; Drug Therapy, Combination; Female; Humans; Intracranial | 2005 |
Repetitive profound thrombocytopenia after treatment with tirofiban: a case report.
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Drug Administration Schedul | 2004 |
Flow cytometric measurement of platelet-leukocyte aggregates: a possible target to monitor platelet function?
Topics: Adenosine Diphosphate; Adult; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Clopidogrel; Fl | 2005 |
Influence of systemic inflammation on the interpretation of response to antiplatelet therapy, monitored by PFA-100.
Topics: Arterial Occlusive Diseases; Aspirin; C-Reactive Protein; Collagen; Diffusion; Drug Monitoring; Epin | 2005 |
Aspirin, but not clopidogrel, reduces collateral conductance in a rabbit model of femoral artery occlusion.
Topics: Animals; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Disease Models, Animal; Electrophysiolog | 2005 |
Acute pain in the tip of the index finger.
Topics: Acute Disease; Amlodipine; Arterial Occlusive Diseases; Aspirin; Cyanosis; Diagnostic Errors; Female | 2005 |
[Emergency measures in acute arterial occlusion. Why there are still colleagues who do it incorrectly?].
Topics: Acute Disease; Angiography; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Embolism; Emergencies | 2006 |
Response to aspirin and clopidogrel monitored with different platelet function methods.
Topics: Aged; Arterial Occlusive Diseases; Aspirin; Automation; Blood Platelets; Clopidogrel; Female; Humans | 2006 |
Surgical revascularisation in patients with severe limb ischaemia induces a pro-thrombotic state.
Topics: Aged; Aged, 80 and over; Antithrombin III; Arterial Occlusive Diseases; Aspirin; Blood Coagulation; | 2006 |
Factitious anticoagulant-resistance as a cause of recurrent arterial bypass graft occlusions.
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Drug Resistance; Drug Therapy, Co | 2007 |
Do the Behring Coagulation Timer and the Platelet Function Analyzer-100 identify the same patients as being aspirin non-responders?
Topics: Aged; Arterial Occlusive Diseases; Aspirin; Automation; Blood Platelets; Clopidogrel; Female; Humans | 2007 |
Rotational vertebrobasilar insufficiency due to dynamic compression of the dominant vertebral artery by the thyroid cartilage and occlusion of the contralateral vertebral artery at C1-2 level.
Topics: Adult; Angiography, Digital Subtraction; Arterial Occlusive Diseases; Aspirin; Cervical Vertebrae; H | 2008 |
Prevention of thrombosis in polycythemia vera and essential thrombocythemia.
Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; | 2008 |
Cerebral subarachnoid blood migration consecutive to a lumbar haematoma after spinal anaesthesia.
Topics: Aged; Anesthesia, Spinal; Anesthetics, Intravenous; Anesthetics, Local; Angioplasty, Balloon; Arteri | 2008 |
[Postoperative antithrombotic therapy in acute occlusion of the major arteries of the extremities].
Topics: Acute Disease; Adolescent; Adult; Aged; Arm; Arterial Occlusive Diseases; Aspirin; Dextrans; Female; | 1980 |
[The effect of lysine acetylsalicylate on hemorrheological changes induced through ischemic exertion in patients with vascular disease].
Topics: Adult; Aged; Analgesics; Arterial Occlusive Diseases; Aspirin; beta-Thromboglobulin; Blood Viscosity | 1983 |
[Medical therapy of peripheral arteriopathies].
Topics: Arterial Occlusive Diseases; Aspirin; Blood Coagulation; Blood Viscosity; Erythrocytes; Humans; Hype | 1984 |
[Therapy of peripheral arterial occlusive diseases. Round table conference].
Topics: Alprostadil; Angioplasty, Balloon; Anti-Bacterial Agents; Anticoagulants; Arterial Occlusive Disease | 1983 |
Role of thromboxanes in vasotonic versus vaso-occlusive angina.
Topics: Angina Pectoris; Angina Pectoris, Variant; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Ca | 1983 |
[Improvement of walking disability and conservative treatment. Guiding principles for drug treatment of chronic arterial occlusive disease (stage I and IIb)].
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Dipyridamole; Fibrinolytic Agents; Humans; Int | 1984 |
Surgical management of the occluded carotid artery.
Topics: Adult; Aged; Arterial Occlusive Diseases; Aspirin; Carotid Arteries; Carotid Artery Diseases; Cerebr | 1984 |
The significance of carotid stenosis or ulceration.
Topics: Angiography; Arterial Occlusive Diseases; Aspirin; Carotid Artery Diseases; Cerebral Infarction; Fem | 1984 |
How much aspirin to inhibit platelet function?
Topics: Administration, Oral; Adult; Aged; Arachidonic Acids; Arterial Occlusive Diseases; Aspirin; Blood Pl | 1982 |
Kawasaki syndrome: a new infectious disease?
Topics: Adrenal Cortex Hormones; Arterial Occlusive Diseases; Aspirin; Child; Coronary Vessels; Epidemiology | 1981 |
[Reconstructive operation of Moyamoya disease and its problems (author's transl)].
Topics: Adult; Arterial Occlusive Diseases; Aspirin; Cerebral Angiography; Cerebral Revascularization; Child | 1981 |
Effect of inhibition of platelet function with carbenicillin or aspirin on experimental canine sudden death.
Topics: Animals; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Carbenicillin; Coronary Disease; Dea | 1981 |
Spectrum of cardiovascular lesions in mucocutaneous lymph node syndrome: analysis of eight cases.
Topics: Adrenal Cortex Hormones; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cardiovascular Diseas | 1980 |
The contralateral diseased but asymptomatic carotid artery: to operate or not? An update.
Topics: Arterial Occlusive Diseases; Aspirin; Carotid Artery Diseases; Cerebrovascular Disorders; Endarterec | 1980 |
Effects of 6-[p-(4-phenylacetylpiperazin-l-yl)-phenyl]-4,5-dihydro-3(2H)-pyridazinone (CCl 17810) and aspirin on experimental arterial thrombosis in rats.
Topics: Animals; Arterial Occlusive Diseases; Aspirin; Carotid Arteries; Male; Platelet Adhesiveness; Pyrida | 1980 |
Platelet changes after placement of aortic prostheses in dogs. II. Impaired surface-induced arterial thrombosis.
Topics: Animals; Aorta; Arterial Occlusive Diseases; Arteries; Aspirin; Blood Coagulation; Blood Platelets; | 1981 |
[5 patients with Takayasu's disease in The Netherlands].
Topics: Adolescent; Adult; Aortography; Arterial Occlusive Diseases; Aspirin; Child; Dipyridamole; Drug Ther | 1995 |
[Arterial occlusion in cutis marmorata teleangiectatica congenita].
Topics: Adolescent; Angiography; Arterial Occlusive Diseases; Arteriovenous Malformations; Aspirin; Dose-Res | 1995 |
Antithrombotic effects of KW-3635, a thromboxane A2-receptor antagonist, in guinea pigs.
Topics: Animals; Arterial Occlusive Diseases; Aspirin; Benzimidazoles; Benzoxepins; Blood Coagulation; Blood | 1994 |
[Chronic arterial insufficiency of the lower limbs. A choice of diagnostic studies and of treatments].
Topics: Amputation, Surgical; Angiography; Arterial Occlusive Diseases; Aspirin; Blood Gas Monitoring, Trans | 1994 |
[20,000 kg aspirin and 45 pages British Medical Journal].
Topics: Arterial Occlusive Diseases; Aspirin; Brain Ischemia; Clinical Trials as Topic; Coronary Disease; Hu | 1994 |
Ticlopidine, trials, and torture.
Topics: Arterial Occlusive Diseases; Aspirin; Cause of Death; Cerebrovascular Disorders; Clinical Trials as | 1994 |
Indications and results after Strecker-stent-application in iliac and SFA.
Topics: Arterial Occlusive Diseases; Aspirin; Female; Femoral Artery; Follow-Up Studies; Heparin; Humans; Il | 1993 |
Low molecular weight heparin-induced thrombocytopenia and thrombosis.
Topics: Adenocarcinoma; Aged; Arterial Occlusive Diseases; Aspirin; Dextrans; Embolism; Female; Femoral Arte | 1996 |
Stenting in the carotid artery: initial experience in 110 patients.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Carotid Artery | 1996 |
[Oral anticoagulation in activated protein C resistance?].
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Drug Resistance; Humans; Male; Middle Aged; Ph | 1996 |
The microvasculature in myeloproliferative disease. A study using retinal fluorescein angiography.
Topics: Adult; Aged; Aged, 80 and over; Allergens; Antineoplastic Agents; Arterial Occlusive Diseases; Aspir | 1996 |
Carotid-subclavian bypass for subclavian artery revascularization: long-term follow-up and effect of antiplatelet therapy.
Topics: Adult; Aged; Angiography; Anticoagulants; Arm; Arterial Occlusive Diseases; Aspirin; Blood Vessel Pr | 1998 |
Protective effect of oral xemilofiban in arterial thrombosis in dogs: increased activity in combination with aspirin.
Topics: Administration, Oral; Animals; Arterial Occlusive Diseases; Aspirin; Benzamidines; Binding Sites; Do | 1998 |
Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis.
Topics: Animals; Antifibrinolytic Agents; Antithrombins; Arterial Occlusive Diseases; Aspirin; Blood Platele | 1999 |
Antithrombotic efficacy of a novel murine antihuman factor IX antibody in rats.
Topics: Anesthesia; Animals; Antibodies, Monoclonal; Anticoagulants; Arterial Occlusive Diseases; Aspirin; B | 1999 |
Generalizing the results of clinical trials to actual practice: the example of clopidogrel therapy for the prevention of vascular events. CAPRA (CAPRIE Actual Practice Rates Analysis) Study Group. Clopidogrel versus Aspirin in Patients at Risk of Ischaemi
Topics: Aged; Arterial Occlusive Diseases; Aspirin; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; C | 1999 |
ME3277, a GPIIb/IIIa antagonist reduces cerebral infarction without enhancing intracranial hemorrhage in photothrombotic occlusion of rabbit middle cerebral artery.
Topics: Amides; Animals; Arterial Occlusive Diseases; Aspirin; Bleeding Time; Cerebrovascular Circulation; F | 2000 |
[Prevention of early thrombotic complications after reconstructive operations in occlusions of the aorto-iliac segment].
Topics: Adult; Aged; Anticoagulants; Aorta, Abdominal; Aortic Diseases; Arterial Occlusive Diseases; Aspirin | 2000 |
A novel synthetic inhibitor of factor Xa decreases early reocclusion and improves 24-h patency after coronary fibrinolysis in dogs.
Topics: Amidines; Animals; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Bleeding Time; Blood Coagul | 2001 |
[Cost effectiveness of clopidogrel in secondary cardiovascular prevention: a cost-effectiveness analysis based on the Caprie Study].
Topics: Adult; Aged; Arterial Occlusive Diseases; Aspirin; Cerebral Hemorrhage; Cerebral Infarction; Clopido | 2001 |
[Occlusion of the arteries of the fingers after hyperextension trauma].
Topics: Adult; Arterial Occlusive Diseases; Aspirin; Athletic Injuries; Female; Finger Injuries; Fingers; He | 2002 |
Prevention of thrombosis.
Topics: Antioxidants; Arterial Occlusive Diseases; Aspirin; Fibrinolytic Agents; Humans; Prostaglandins; Thr | 1977 |
Evaluation of antiinflammatory and antithrombotic drugs in pulmonary and arterial thrombosis.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Animals; Anti-Inflammatory Agents; Arterial Occlusive Di | 1979 |
[Therapy with anticoagulants and platelet aggregation inhibitors in extracranial vascular stenoses and occlusions].
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cerebral Infarction; Cerebrovascular Disorders | 1979 |
[Conservative therapy of peripheral arterial occlusive diseases. Possibilities and basic principles].
Topics: Arterial Occlusive Diseases; Aspirin; Coumarins; Dextrans; Digoxin; Exercise Therapy; Humans; Vasodi | 1978 |
Aspirin-induced increase in collateral flow after acute coronary occlusion in dogs.
Topics: Acute Disease; Adenosine Diphosphate; Animals; Arterial Occlusive Diseases; Aspirin; Collateral Circ | 1979 |
Measurement of platelet regeneration time in cardiovascular patients.
Topics: Adult; Aged; Arachidonic Acids; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Cardiovascula | 1979 |
[Functional peripheral ischemia].
Topics: Arterial Occlusive Diseases; Aspirin; Cyanosis; Dihydroergotamine; Erythromelalgia; Hot Temperature; | 1979 |
Effect of acetylsalicylic acid on experimentally induced arterial thrombosis in rats.
Topics: Animals; Arterial Occlusive Diseases; Aspirin; Male; Platelet Aggregation; Rats; Thrombosis; Time Fa | 1977 |
Aspirin in the prophylaxis of venous and arterial diseases.
Topics: Arterial Occlusive Diseases; Aspirin; Humans; Platelet Adhesiveness; Platelet Aggregation; Thromboph | 1977 |
[Treatment of transient ischemic attacks (author's transl)].
Topics: Angiography; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Endarterectomy; Humans; Ischemic | 1978 |
[Thrombocyte-aggregation inhibitors following open or semi-open endarterectomy-preliminary results of a prospective study].
Topics: Arterial Occlusive Diseases; Aspirin; Dipyridamole; Endarterectomy; Humans; Platelet Aggregation; Po | 1978 |
[Platelet aggregation in atherosclerotic disease after administration of lysine acetylsalicylate].
Topics: Adult; Aged; Angina Pectoris; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Coronary Disea | 1978 |
[Results of clinical studies on the effect of aggregation inhibitors in arterial diseases].
Topics: Arterial Occlusive Diseases; Aspirin; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1979 |
Spontaneous platelet aggregation in arterial insufficiency: mechanisms and implications.
Topics: Adenosine; Adult; Aged; Angina Pectoris; Apyrase; Arterial Occlusive Diseases; Aspirin; Coronary Dis | 1976 |
[Interesting changes in blood fibrinolysis following administration of acetylsalicylic acid in vascular diseases of the lower limbs].
Topics: Adult; Aged; Arterial Occlusive Diseases; Aspirin; Blood Coagulation Tests; Fibrinolysis; Humans; Le | 1976 |
Prevention of stroke.
Topics: Age Factors; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Auscultation; Cerebral Angiograph | 1975 |
The effect of a new anti-inflammatory agent, the ethoxy methyl ester of N-(2,6-dichloro-m-tolyl)-anthranilic acid (A3), on platelet behaviour "in vivo" and "in vitro".
Topics: Administration, Oral; Administration, Topical; Animals; Anti-Inflammatory Agents; Arterial Occlusive | 1975 |
[Circulatory disorders can be prevented].
Topics: Arterial Occlusive Diseases; Aspirin; Blood Coagulation; Humans | 1976 |
[Thrombophilia in patients with arterial occlusive diseases and its therapeutic modification].
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Blood Coagulation Tests; Coronary Disease; Cor | 1991 |
Femoro-popliteal artery occlusions treated by percutaneous transluminal angioplasty and enclosed thrombolysis: results in 55 patients.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Combined Modali | 1991 |
[Effect of antiplatelet therapy on prevention of thrombotic diseases].
Topics: Arachidonic Acid; Arterial Occlusive Diseases; Aspirin; Cerebral Infarction; Humans; Myocardial Infa | 1991 |
[Rate of recurrence following PTA of pelvic-leg arteries in relation to selected risk factors and antithrombotic after care].
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Combined Modality Therapy; Coumarins; Fo | 1991 |
Overt gastrointestinal bleeding in the course of chronic low-dose aspirin administration for secondary prevention of arterial occlusive disease.
Topics: Arterial Occlusive Diseases; Aspirin; Gastrointestinal Hemorrhage; Humans | 1991 |
[Chronic arterial occlusive diseases--drug therapy and thromboxane A2 synthetase inhibitor].
Topics: Arterial Occlusive Diseases; Aspirin; Chronic Disease; Epoprostenol; Fatty Acids, Monounsaturated; H | 1991 |
Successful therapy of the prostaglandin defect "Wien-Hietzing" (lack of platelet high-affinity binding sites for prostaglandin I2).
Topics: Arterial Occlusive Diseases; Aspirin; Blood Platelets; Child; Epoprostenol; Female; Follow-Up Studie | 1990 |
[Conservative therapy of peripheral arterial occlusive disease].
Topics: Alprostadil; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Dipyridamole; Exercise; Humans; L | 1990 |
Overt gastrointestinal bleeding in the course of chronic low-dose aspirin administration for secondary prevention of arterial occlusive disease.
Topics: Aged; Arterial Occlusive Diseases; Aspirin; Female; Gastritis; Gastrointestinal Hemorrhage; Humans; | 1990 |
Platelet deposition at angioplasty sites and its relation to restenosis in human iliac and femoropopliteal arteries.
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Constriction, Pathologi | 1989 |
[Lack of effect of low dose acetylsalicylic acid (100 mg/die) on thrombocyte survival and beta-thromboglobulin (beta-TG) and platelet factor 4 (PF 4) in patients with peripheral arterial occlusive disease].
Topics: Arterial Occlusive Diseases; Aspirin; beta-Thromboglobulin; Blood Platelets; Cell Survival; Female; | 1989 |
The role of carotid endarterectomy in asymptomatic carotid stenosis: status of the Veterans Administration study.
Topics: Arterial Occlusive Diseases; Aspirin; Carotid Arteries; Carotid Artery Diseases; Endarterectomy; Hum | 1989 |
Effect of acetyl salicylic acid on increased production of thromboxane after aortic graft surgery.
Topics: Aged; Aorta, Abdominal; Aortic Aneurysm; Aortic Diseases; Arterial Occlusive Diseases; Aspirin; Bloo | 1989 |
Fibromuscular dysplasia of the carotid arteries complicating pregnancy.
Topics: Adult; Arterial Occlusive Diseases; Aspirin; Carotid Artery Diseases; Female; Fibromuscular Dysplasi | 1989 |
[Percutaneous transluminal recanalization of chronic stenoses and occlusions of peripheral arteries].
Topics: Angiography; Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Dipyridamole; Femoral Arter | 1985 |
Influence of acetylsalicylic acid (1.0 g/day) on platelet survival time, beta-thromboglobulin and platelet factor 4 in patients with peripheral arterial occlusive disease.
Topics: Adult; Aged; Arterial Occlusive Diseases; Aspirin; beta-Thromboglobulin; Blood Platelets; Cell Survi | 1987 |
Lack of elevation of beta-thromboglobulin and platelet factor 4 in plasma during exercise in patients with chronic peripheral arterial occlusive disease.
Topics: Adult; Aged; Arterial Occlusive Diseases; Aspirin; beta-Thromboglobulin; Exercise Test; Female; Huma | 1987 |
Restenosis after arterial angioplasty: a hemorrheologic response to injury.
Topics: Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Arteries; Aspirin; Microscopy, Electron, | 1987 |
[Secondary prevention of peripheral arterial occlusive diseases].
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Coumarins; Dipyridamole; Humans; Sulfinp | 1987 |
Blue toe syndrome: treatment with anticoagulants and delayed percutaneous transluminal angioplasty.
Topics: Adult; Aged; Angioplasty, Balloon; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cyanosis; D | 1988 |
Lack of influence of low-dose acetylsalicylic acid (100 mg daily) on platelet survival time, beta-thromboglobulin and platelet factor 4 in patients with peripheral arterial occlusive disease.
Topics: Adult; Aged; Arterial Occlusive Diseases; Aspirin; beta-Thromboglobulin; Blood Platelets; Cell Survi | 1988 |
New pharmacologic approaches to thromboembolic disorders.
Topics: Adenylyl Cyclases; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Cyclic AMP | 1985 |
Circulating lupus type anticoagulant and pulmonary hypertension associated with mixed connective tissue disease.
Topics: Adult; Arterial Occlusive Diseases; Aspirin; Blood Coagulation Factors; Dipyridamole; Female; Hand; | 1986 |
Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease.
Topics: Acute Disease; Adult; Aged; Arterial Occlusive Diseases; Aspirin; Basilar Artery; Female; Fibrinolyt | 1988 |
20 mg aspirin daily--evidence for a clinical future of this extremely low-dose in arterial disease?
Topics: Adult; Arterial Occlusive Diseases; Aspirin; Dose-Response Relationship, Drug; Female; Humans; Male; | 1988 |
Effect of high and low-dose aspirin on circulating endothelial cells.
Topics: Arterial Occlusive Diseases; Aspirin; Dose-Response Relationship, Drug; Endothelium, Vascular; Human | 1988 |
Management of transient ischemic attacks.
Topics: Arterial Occlusive Diseases; Aspirin; Carotid Artery Diseases; Cerebrovascular Disorders; Embolism; | 1986 |
[Whole blood viscosity in patients with acral arterial occlusive diseases and their modification by rheologically active drugs].
Topics: Adult; Arterial Occlusive Diseases; Aspirin; Blood Viscosity; Drug Therapy, Combination; Female; Hum | 1987 |
[Prevention and medical treatment of polyregional vascular lesions].
Topics: Adult; Anticoagulants; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Diet; Dipyridamole; D | 1985 |
Regulation of increase in anastomotic blood flow following pulmonary arterial occlusion.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arterial Occlusive Diseases; Arteriovenous Anastomosis; Aspir | 1985 |
[Computer-assisted in vivo study of capillary permeability].
Topics: Adolescent; Adult; Aged; Alprostadil; Arterial Occlusive Diseases; Aspirin; Capillary Permeability; | 1985 |
Carotid endarterectomy. One solution to the stroke problem.
Topics: Adult; Aged; Arterial Occlusive Diseases; Aspirin; Carotid Arteries; Carotid Artery Diseases; Cerebr | 1985 |
Peripheral vascular disease: treatment and referral of the elderly. Part II.
Topics: Aged; Arterial Occlusive Diseases; Aspirin; Brain Ischemia; Carotid Artery Diseases; Cerebrovascular | 1985 |
[Anti-platelet aggregation action and paradoxical effects of acetylsalicylic acid].
Topics: Adult; Aged; Arterial Occlusive Diseases; Aspirin; Cerebrovascular Disorders; Coronary Disease; Extr | 1985 |
Antiplatelet drugs improve the patency rates after femoro-popliteal endarterectomy.
Topics: Arterial Occlusive Diseases; Aspirin; Blood Platelets; Dipyridamole; Endarterectomy; Female; Femoral | 1985 |
Impaired arteriolar vasodilation induced by thrombosis of a coronary arterial stenosis.
Topics: Animals; Arterial Occlusive Diseases; Aspirin; Coronary Circulation; Heart Rate; Hemodynamics; Imida | 1985 |
[Experimental investigation of the effect of a combination of quinine, lithium and salicylic acid by means of various methods].
Topics: Angiography; Anti-Inflammatory Agents; Arterial Occlusive Diseases; Arthritis; Aspirin; Drug Combina | 1974 |
[Experimental platelet aggregation and arterial thrombosis. Effect of aspirin].
Topics: Adenosine Diphosphate; Animals; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Collagen; Epi | 1973 |
[Prophylaxis and treatment of thromboses of the deep leg veins with acetylsalicylic acid (author's transl)].
Topics: Arterial Occlusive Diseases; Aspirin; Blood Platelets; Humans; Leg; Myocardial Infarction; Platelet | 1973 |